Lumen Technologies, Inc. Announces Pricing of its 7.500% Senior Notes Due 2037

Lumen Technologies, Inc. Announces Pricing of its 7.500% Senior Notes Due 2037

DENVER–(BUSINESS WIRE)–Lumen Technologies, Inc. (“Lumen,” “us,” “we” or “our”) (NYSE: LUMN) today announced that its wholly-owned subsidiary, Level 3 Financing, Inc. (“Level 3 Financing”), has agreed to sell $1 billion aggregate principal amount of its 7.500% Senior Notes due 2037 (the “Notes”).

The Notes were priced to investors at a price of 100.000% of their aggregate principal amount and will mature on February 15, 2037. Upon issuance, the Notes will be fully and unconditionally guaranteed, jointly and severally, on an unsubordinated and unsecured basis by Level 3 Parent, LLC, the direct parent of Level 3 Financing, and certain unregulated subsidiaries of Level 3 Financing.

Level 3 Financing intends to use a portion of the net proceeds from this offering to fund the purchase of its, Lumen’s and Qwest Capital Funding’s (“QCF”) unsecured notes (collectively, the “Existing Group Tender Notes”) pursuant to a concurrent cash tender offer by Level 3 Financing, Lumen, and QCF to purchase their respective series of Existing Group Tender Notes pursuant to and on the terms and subject to the conditions set forth in an offer to purchase dated May 6, 2026 (the “Statement”) and to pay related fees and expenses. To the extent not applied to purchase the Existing Group Tender Notes in the Tender Offers and to pay related fees and expenses, Level 3 Financing intends to use the net proceeds for general corporate purposes. The offering of the Notes is expected to be completed on May 21, 2026, subject to the satisfaction or waiver of customary closing conditions.

The Notes will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws in the United States and may not be offered or sold in the United States absent registration or an exemption from the applicable registration requirements. Accordingly, the Notes are being offered and sold only to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A promulgated under the Securities Act and to non-U.S. persons outside the United States in accordance with Regulation S promulgated under the Securities Act. The Notes will not have registration rights.

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, the Notes, nor will there be any sale of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release does not constitute an offer to buy or the solicitation of an offer to sell any Existing Group Tender Notes, nor will there be any purchase of Existing Group Tender Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Lumen Technologies

Lumen is unleashing the world’s digital potential. We ignite business growth by connecting people, data, and applications – quickly, securely, and effortlessly. As the trusted network for AI, Lumen uses the scale of our network to help companies realize AI’s full potential. From metro connectivity to long-haul data transport to our edge cloud, security, managed service, and digital platform capabilities, we meet our customers’ needs today and as they build for tomorrow.

Lumen and Lumen Technologies are registered trademarks of Lumen Technologies, Inc. in the United States. Level 3 Financing, Inc. and Qwest Capital Funding, Inc. are wholly owned affiliates of Lumen Technologies, Inc.

Forward-Looking Statements

Except for historical and factual information, the matters set forth in this release and other of our oral or written statements identified by words such as “estimates,” “expects,” “anticipates,” “believes,” “plans,” “intends,” and similar expressions are forward-looking statements. These forward-looking statements are not guarantees of future results and are based on current expectations only, are inherently speculative, and are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control. Actual events and results may differ materially from those anticipated, estimated, projected or implied by us in those statements if one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect. Factors that could affect actual results include, but are not limited to: failure to satisfy or waive the conditions to consummation of the Notes offering or the conditions set forth in the Statement; corporate developments that could preclude, impair or delay the above-described transactions due to restrictions under the federal securities laws; changes in Level 3 Financing’s credit ratings; changes in the cash requirements, financial position, financing plans or investment plans of Level 3 Financing or its affiliates; changes in general market, economic, tax, regulatory or industry conditions that impact the ability or willingness of Level 3 Financing, Lumen, or QCF to consummate the above-described transactions on the terms described above or at all; and other risks referenced from time to time in the filings of Lumen or Level 3 Parent, LLC with the Securities and Exchange Commission. We undertake no obligation to publicly update or revise any forward-looking statements for any reason, whether as a result of new information, future events or developments, changed circumstances, or otherwise. We may change our intentions, strategies or plans (including our plans expressed herein) without notice at any time and for any reason.

Media Contact:

Anita J. Gomes

[email protected]

+1 858-229-8538

Investor Contact:

Jim Breen, CFA

[email protected]

+1 603-404-7003

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Data Management Security Apps/Applications Technology Software Networks Artificial Intelligence

MEDIA:

Logo
Logo

Ring Energy Releases First Quarter 2026 Results

THE WOODLANDS, Texas, May 06, 2026 (GLOBE NEWSWIRE) — Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported operational and financial results for the first quarter of 2026.

First Quarter 2026 Highlights

  • Sold 12,276 barrels of oil per day (“Bo/d”) and 19,351 barrels of oil equivalent per day (“Boe/d”) both of which were essentially at the mid-point of guidance;
  • Reported a net loss of $220.6 million, or $(1.06) per diluted share, driven primarily by a $162.1 million non-cash ceiling test impairment and a $77.0 million unrealized mark-to-market derivative loss related to changes in forward commodity prices;
  • Generated Adjusted Net Income1 of $7.4 million, or $0.04 per diluted share;
  • Closed the sale of ~ 200 Boe/d of non-operated NWS assets for $4.5 million, valued at approximately 4.5 times estimated next twelve months cash flow2;
  • Incurred Lease Operating Expense (“LOE”) of $10.41 per Boe, 3% below the low end of guidance due to ongoing efforts to reduce costs;
  • Invested $34.5 million in capital expenditures, accelerating targeted infrastructure investments to expand flexibility and unlock more capital efficient longer lateral inventory;
  • Improved NWS spud‑to‑TD drilling time by ~15% versus the 2025 average;
  • Generated net cash flow from operating activities of $25.9 million and remained cash flow positive for the 26th consecutive quarter; and
  • Increased borrowings by $6 million to accelerate the capture of attractively priced opportunities while maintaining liquidity of $160.0 million as of March 31, 2026.

Management Commentary

Mr. Paul D. McKinney, Chairman of the Board and Chief Executive Officer, commented, “We successfully delivered on our sales guidance, handsomely beat on LOE, while investing ahead of our drilling campaign and extending our track record to 26 consecutive quarters of positive cash flow. Looking to the future, we believe the market has yet to recognize the potential impact of supply disruptions stemming from the Iranian Conflict and what that could mean for long term oil prices. Because we expect oil prices to remain elevated longer than the market currently implies, we made targeted adjustments late in the quarter to capture attractively priced opportunities that provide optionality and the potential to meaningfully expand our drilling inventory, improve capital efficiency and build long term stockholder value.”

Mr. McKinney concluded, “While we remained focused on operating within Adjusted Free Cash Flow1 during the first quarter of 2026, we temporarily paused debt reduction to invest in select opportunities which are compelling on a risk-adjusted basis. We are acting early to capture upside potential before sustained higher oil prices translate into higher costs and increased competition. We believe these actions should improve our production later in the year and into 2027; however, it is too early to reflect any increases in our production guidance at this time. Looking ahead, we expect to resume our focus on debt reduction during the remainder of 2026, as we balance growth with strengthening our balance sheet and increasing the Company’s size and scale.”

___________________________________

1 A non-GAAP financial measure; see the “Non-GAAP Financial Information” section in this release for more information including reconciliations to the most comparable GAAP measures.

2 The cash flow for the next twelve months (“NTM”) represents field level cash flow based on a strip price as of January 12, 2026.

Summary Results and Additional Key Items

  Q1 2026 Q4 2025 Q1 2026 to Q4 2025 % Change Q1 2025 Q1 2026 to Q1 2025 % Change
Average Daily Sales Volumes (Boe/d)   19,351     20,508   (6 )%   18,392 5 %
Crude Oil (Bo/d)   12,276     13,124   (6 )%   12,074 2 %
Net Sales (MBoe)   1,741.6     1,886.8   (8 )%   1,655.3 5 %
Realized Price – All Products ($/Boe) $ 42.30   $ 35.45   19 % $ 47.78 (11 )%
Realized Price – Crude Oil ($/Bo) $ 68.97   $ 57.47   20 % $ 70.40 (2 )%
Revenues ($MM) $ 73.7   $ 66.9   10 % $ 79.1 (7 )%
Net Income (Loss) ($MM) $ (220.6 ) $ (12.8 ) 1623 % $ 9.1 (2524 )%
Adjusted Net Income1($MM) $ 7.4   $ 3.6   106 % $ 10.7 (31 )%
Adjusted EBITDA1($MM) $ 38.3   $ 38.4   % $ 46.4 (17 )%
Capital Expenditures ($MM) $ 34.5   $ 24.3   42 % $ 32.5 6 %
Adjusted Free Cash Flow1($MM) $ 0.2   $ 5.7   (96 )% $ 5.8 (97 )%


(1) Adjusted Net Income, Adjusted EBITDA, and Adjusted Free Cash Flow are non-GAAP financial measures, which are described in more detail and reconciled to the most comparable GAAP measures, in the tables shown later in this release under “Non-GAAP Financial Information.” In addition, see section titled “Condensed Operating Data” for additional details concerning costs and expenses presented below.

Select Expenses and Other Items

  Q1 2026 Q4 2025 Q1 2026 to Q4 2025 % Change Q1 2025 Q1 2026 to Q1 2025 % Change
Lease operating expenses (“LOE”) ($MM) $ 18.1   $ 18.9 (4 )% $ 19.7   (8 )%
Lease operating expenses ($/BOE) $ 10.41   $ 10.02 4 % $ 11.89   (12 )%
Depreciation, depletion and amortization ($MM) $ 21.4   $ 23.0 (7 )% $ 22.6   (5 )%
Depreciation, depletion and amortization ($/BOE) $ 12.29   $ 12.19 1 % $ 13.66   (10 )%
General and administrative expenses (“G&A”) ($MM) $ 7.4   $ 8.0 (8 )% $ 8.6   (14 )%
General and administrative expenses ($/BOE) $ 4.27   $ 4.26 % $ 5.21   (18 )%
G&A excluding share-based compensation ($MM) $ 5.9   $ 6.6 (11 )% $ 6.9   (14 )%
G&A excluding share-based compensation ($/BOE) $ 3.40   $ 3.47 (2 )% $ 4.19   (19 )%
G&A excluding share-based compensation & transaction costs ($MM) $ 5.9   $ 6.5 (9 )% $ 6.9   (14 )%
G&A excluding share-based compensation & transaction costs ($/BOE) $ 3.40   $ 3.46 (2 )% $ 4.18   (19 )%
Interest expense ($MM) $ 8.6   $ 9.1 (5 )% $ 9.5   (9 )%
Interest expense ($/BOE) $ 4.94   $ 4.83 2 % $ 5.74   (14 )%
Gain (loss) on derivative contracts ($MM)(1) $ (82.2 ) $ 17.5 (570 )% $ (0.9 ) (9033 )%
Realized gain (loss) on derivative contracts ($MM) $ (5.2 ) $ 2.7 (293 )% $ (0.5 ) (940 )%
Unrealized gain (loss) on derivative contracts ($MM) $ (77.0 ) $ 14.8 (620 )% $ (0.4 ) (19150 )%


(1) A summary listing of the Company’s outstanding derivative positions as of May 5, 2026 is included in the tables shown later in this release. As of May 5, 2026, for the remainder (April through December) of 2026, the Company has approximately 2.6 million barrels of oil (approximately 72% of oil sales guidance midpoint) hedged at an average upside protection price of $73.27 and approximately 3.8 billion cubic feet of natural gas (approximately 73% of natural gas sales guidance midpoint) hedged at an average downside protection price of $3.78.

Balance Sheet and
Liquidity

Total liquidity (defined as cash and cash equivalents plus borrowing base availability under the Company’s credit facility) at March 31, 2026 was approximately $160.0 million, consisting of $159.0 million of availability under our revolving credit facility, which included a reduction of $35 thousand for letters of credit, and $1.0 million in cash and cash equivalents. On March 31, 2026, the Company had $426 million in borrowings outstanding on its credit facility that has a current borrowing base of $585 million. This reflects an increase of $6 million from the balance of $420 million at December 31, 2025. The Company intends to resume debt reduction, dependent on market conditions, the timing and level of capital spending, and other considerations.

Ceiling Test Impairment

The Company accounts for its assets under the full cost method of accounting, which requires calculation of the limitation on capitalized costs (the full cost ceiling) each quarter. Due to a decrease in the twelve month average SEC commodity pricing over the past quarter, the Company recorded a non-cash impairment charge of $162.1 million in the first quarter of 2026. This non-cash charge had no net impact on cash flows.

Drilling and Completion Activity

In 1Q 2026 the Company continued execution of its development program across its core operated positions. In the Northwest Shelf (Yoakum County), Ring drilled and completed five one-mile horizontal wells, each with a working interest of approximately 91%. In addition, the Company in the Central Basin Platform (Crane County), completed one previously drilled one-mile horizontal DUC well, and drilled and completed one vertical well, with a 100% working interest.

The table below sets forth Ring’s drilling and completion activities in the first quarter of 2026:

Quarter   Area   Wells Drilled   Wells Completed
             
1Q 2026   Northwest Shelf (Horizontal)   5   5
    Central Basin Platform (Horizontal)(1)     1
    Central Basin Platform (Vertical)   1   1
    Total   6   7


(1) The horizontal well completed in the Central Basin Platform in the first quarter of 2026 is the completion of a previously drilled but uncompleted (“DUC”) well.

Remaining
Quarters of
2026
Sales Volumes, Capital Investment and Operating Expense Guidance

The guidance in the table below represents the Company’s current good faith estimate of the range of likely future results. Guidance could be affected by the factors discussed below in the “Safe Harbor Statement” section.

    Q2 Q3 Q4
      2026     2026     2026  
Sales Volumes:        
Total Oil (Bo/d)   12,450 – 13,450 12,750 – 13,750 12,800 – 13,800

Midpoint (Bo/d)
   
12,950
   
13,250
   
13,300
 
Total (Boe/d)   19,400 – 21,000 19,700 – 21,300 19,800 – 21,400

Midpoint (Boe/d)
   
20,200
   
20,500
   
20,600
 
Oil (%)     64 %   65 %   65 %
NGLs (%)     20 %   20 %   20 %
Gas (%)     16 %   15 %   15 %
         
Capital Program:        
Capital spending(1)(millions)   $28 – $36 $27 – $35 $17 – $25

Midpoint (millions)
 
$

32
 
$

31
 
$

21
 
New Hz wells drilled   5 – 7 5 – 7 3 – 5
New Vertical wells drilled   1 – 2 1 – 2   1  
Wells completed and online   6 – 9 6 – 9 4 – 6
         
Operating Expenses:        
LOE (per Boe)   $10.05 – $11.05 $10.00 – $11.00 $10.00 – $11.00

Midpoint (per Boe)
 
$

10.55
 
$

10.50
 
$

10.50
 



(1)
In addition to Company-directed drilling and completion activities, the capital spending outlook includes funds for targeted well recompletions, capital workovers, infrastructure upgrades, and well reactivations. Also included is anticipated spending for leasing acreage; and non-operated drilling, completion, capital workovers, and facility improvements.

Conference Call Information

Ring will hold a conference call on Thursday, May 7, 2026 at 11:00 a.m. ET (10 a.m. CT) to discuss its 1Q 2026 operational and financial results. An updated investor presentation will be posted to the Company’s website prior to the conference call.

To participate in the conference call, interested parties should dial 833-953-2433 at least five minutes before the call is to begin. Please reference the “Ring Energy 1Q 2026 Earnings Conference Call”. International callers may participate by dialing 412-317-5762. The call will also be webcast and available on Ring’s website at www.ringenergy.com under “Investors” on the “News & Events” page. An audio replay will also be available on the Company’s website following the call.

About Ring Energy, Inc.

Ring Energy, Inc. is an oil and gas exploration, development, and production company with current operations focused on the development of its Permian Basin assets. For additional information, please visit www.ringenergy.com.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements involve a wide variety of risks and uncertainties, and include, without limitation, statements with respect to the Company’s strategy and prospects. The forward-looking statements include statements about the expected future reserves, production, financial position, business strategy, revenues, earnings, costs, capital expenditures and debt levels of the Company, and plans and objectives of management for future operations. Forward-looking statements also include assumptions and projections for remaining quarters of 2026 guidance for sales volumes, oil, NGL and natural gas mix as a percentage of total sales, capital expenditures, operating expenses and the projected impacts thereon. Forward-looking statements are based on current expectations and assumptions and analyses made by Ring and its management in light of their experience and perception of historical trends, current conditions and expected future developments, as well as other factors appropriate under the circumstances. However, whether actual results and developments will conform to expectations is subject to a number of material risks and uncertainties, including but not limited to: declines in oil, natural gas liquids or natural gas prices; the level of success in exploration, development and production activities; the impact of worldwide political, military and armed conflict (including the impact of the ongoing conflict with Iran and the closure of the Strait of Hormuz); adverse weather conditions that may negatively impact development or production activities particularly in the winter; the timing of exploration and development expenditures; inaccuracies of reserve estimates or assumptions underlying them; revisions to reserve estimates as a result of changes in commodity prices; impacts to financial statements as a result of impairment write-downs; risks related to level of indebtedness and periodic redeterminations of the borrowing base and interest rates under the Company’s credit facility; Ring’s ability to generate sufficient cash flows from operations to meet the internally funded portion of its capital expenditures budget; the impacts of hedging on results of operations; changes in U.S. energy, environmental, monetary, tax and trade policies, including with respect to tariffs or other trade barriers, and any resulting trade tensions; cost and availability of transportation and storage capacity as a result of oversupply, government regulation or other factors; and Ring’s ability to replace oil and natural gas reserves. Such statements are subject to certain risks and uncertainties which are disclosed in the Company’s reports filed with the Securities and Exchange Commission (“SEC”), including its Form 10-K for the fiscal year ended December 31, 2025, and its other SEC filings. Ring undertakes no obligation to revise or update publicly any forward-looking statements, except as required by law.

Contact Information

Al Petrie Advisors
Al Petrie, Senior Partner
Phone: 281-975-2146 Email: [email protected]

RING ENERGY, INC.
Condensed Statements of Operations
(Unaudited)
 
  Three Months Ended
  March 31,   December 31,   March 31,
    2026       2025       2025  
           
Oil, Natural Gas, and Natural Gas Liquids Revenues $ 73,671,664     $ 66,882,770     $ 79,091,207  
           
Costs and Operating Expenses          
Lease operating expenses   18,122,344       18,911,801       19,677,552  
Gathering, transportation and processing costs   117,049       121,097       203,612  
Ad valorem taxes   2,202,537       2,279,266       1,532,108  
Oil and natural gas production taxes   3,553,891       3,224,183       3,584,455  
Depreciation, depletion and amortization   21,405,948       23,002,908       22,615,983  
Ceiling test impairment   162,086,257       35,913,116        
Asset retirement obligation accretion   395,496       390,892       326,549  
Operating lease expense   175,091       175,090       175,091  
General and administrative expense   7,438,778       8,030,310       8,619,976  
           
Total Costs and Operating Expenses   215,497,391       92,048,663       56,735,326  
           
Income (Loss) from Operations   (141,825,727 )     (25,165,893 )     22,355,881  
           
Other Income (Expense)          
Interest income   70,529       56,910       90,058  
Interest (expense)   (8,599,609 )     (9,122,419 )     (9,498,786 )
Gain (loss) on derivative contracts   (82,230,925 )     17,495,270       (928,790 )
Gain (loss) on disposal of assets         60,855       124,610  
Other income   5,837       29,582       8,942  
Net Other Income (Expense)   (90,754,168 )     8,520,198       (10,203,966 )
           
Income (Loss) Before Benefit from (Provision for) Income Taxes   (232,579,895 )     (16,645,695 )     12,151,915  
           
Benefit from (Provision for) Income Taxes   11,988,413       3,800,401       (3,041,177 )
           
Net Income (Loss) $ (220,591,482 )   $ (12,845,294 )   $ 9,110,738  
           
Basic Earnings (Loss) per Share $ (1.06 )   $ (0.06 )   $ 0.05  
Diluted Earnings (Loss) per Share $ (1.06 )   $ (0.06 )   $ 0.05  
           
Basic Weighted-Average Shares Outstanding   208,558,546       207,233,067       199,314,182  
Diluted Weighted-Average Shares Outstanding   208,558,546       207,233,067       201,072,594  



RING ENERGY, INC.
Condensed Operating Data
(Unaudited)
 
  Three Months Ended
  March 31,   December 31,   March 31,
    2026       2025       2025  
           
Net sales volumes:          
Oil (Bbls)   1,104,823       1,207,425       1,086,694  
Natural gas (Mcf)   1,689,512       1,808,355       1,615,196  
Natural gas liquids (Bbls)   355,173       377,937       299,366  
Total oil, natural gas and natural gas liquids (Boe)(1)   1,741,581       1,886,755       1,655,259  
           
% Oil   64 %     64 %     66 %
% Natural Gas   16 %     16 %     16 %
% Natural Gas Liquids   20 %     20 %     18 %
           
Average daily sales volumes:          
Oil (Bbls/d)   12,276       13,124       12,074  
Natural gas (Mcf/d)   18,772       19,656       17,947  
Natural gas liquids (Bbls/d)   3,946       4,108       3,326  
Average daily equivalent sales (Boe/d)   19,351       20,508       18,392  
           
Average realized sales prices:          
Oil ($/Bbl) $ 68.97     $ 57.47     $ 70.40  
Natural gas ($/Mcf)   (2.54 )     (2.49 )     (0.19 )
Natural gas liquids ($/Bbls)   4.96       5.29       9.65  
Barrel of oil equivalent ($/Boe) $ 42.30     $ 35.45     $ 47.78  
           
Average costs and expenses per Boe ($/Boe):          
Lease operating expenses $ 10.41     $ 10.02     $ 11.89  
Gathering, transportation and processing costs   0.07       0.06       0.12  
Ad valorem taxes   1.26       1.21       0.93  
Oil and natural gas production taxes   2.04       1.71       2.17  
Depreciation, depletion and amortization   12.29       12.19       13.66  
Ceiling test impairment   93.07       19.03        
Asset retirement obligation accretion   0.23       0.21       0.20  
Operating lease expense   0.10       0.09       0.11  
G&A (including share-based compensation)   4.27       4.26       5.21  
G&A (excluding share-based compensation)   3.40       3.47       4.19  
G&A (excluding share-based compensation and transaction costs)   3.40       3.46       4.18  


(1) Boe is determined using the ratio of six Mcf of natural gas to one Bbl of oil (totals may not compute due to rounding.) The conversion ratio does not assume price equivalency and the price on an equivalent basis for oil, natural gas, and natural gas liquids may differ significantly.

RING ENERGY, INC.
Condensed Balance Sheets
(Unaudited)
 
    As of
    March 31, 2026   December 31, 2025
ASSETS        
Current Assets        
Cash and cash equivalents   $ 1,040,636     $ 902,913  
Accounts receivable     45,731,039       30,938,908  
Joint interest billing receivables, net     901,472       1,623,991  
Derivative assets     4,016,834       21,468,134  
Inventory     6,148,963       5,312,715  
Prepaid expenses and other assets     1,426,496       1,822,751  
Total Current Assets     59,265,440       62,069,412  
Properties and Equipment        
Oil and natural gas properties, full cost method     1,761,765,033       1,891,510,431  
Financing lease asset subject to depreciation     3,676,412       3,633,586  
Fixed assets subject to depreciation     3,504,788       3,504,788  
Total Properties and Equipment     1,768,946,233       1,898,648,805  
Accumulated depreciation, depletion and amortization     (590,499,944 )     (569,180,901 )
Net Properties and Equipment     1,178,446,289       1,329,467,904  
Operating lease asset     1,125,245       1,285,159  
Derivative assets     7,199,724       9,739,430  
Deferred financing costs     8,678,656       9,337,344  
Total Assets   $ 1,254,715,354     $ 1,411,899,249  
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current Liabilities        
Accounts payable   $ 102,616,433     $ 90,258,731  
Income tax liability     535,318       356,436  
Financing lease liability     686,697       730,564  
Operating lease liability     539,464       586,614  
Derivative liabilities     43,082,871       841,193  
Notes payable           505,752  
Asset retirement obligations     397,413       418,526  
Total Current Liabilities     147,858,196       93,697,816  
         
Non-current Liabilities        
Deferred income taxes     10,214,701       22,298,701  
Revolving line of credit     426,000,000       420,000,000  
Financing lease liability, less current portion     487,110       593,146  
Operating lease liability, less current portion     695,226       819,223  
Derivative liabilities     17,234,923       2,512,692  
Asset retirement obligations     30,247,250       29,972,429  
Total Liabilities     632,737,406       569,894,007  
Commitments and contingencies        
Stockholders’ Equity        
Preferred stock – $0.001 par value; 50,000,000 shares authorized; no shares issued or outstanding            
Common stock – $0.001 par value; 450,000,000 shares authorized; 209,395,110 shares and 207,656,929 shares issued and outstanding, respectively     209,395       207,657  
Additional paid-in capital     813,340,036       812,777,586  
Retained earnings (Accumulated deficit)     (191,571,483 )     29,019,999  
Total Stockholders’ Equity     621,977,948       842,005,242  
Total Liabilities and Stockholders’ Equity   $ 1,254,715,354     $ 1,411,899,249  



RING ENERGY, INC.
Condensed Statements of Cash Flows
(Unaudited)
 
  Three Months Ended
  March 31,   December 31,   March 31,
    2026       2025       2025  
Cash Flows From Operating Activities          
Net income (loss) $ (220,591,482 )   $ (12,845,294 )   $ 9,110,738  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation, depletion and amortization   21,405,948       23,002,908       22,615,983  
Ceiling test impairment   162,086,257       35,913,116        
Asset retirement obligation accretion   395,496       390,892       326,549  
Amortization of deferred financing costs   694,148       691,228       1,238,493  
Share-based compensation   1,524,808       1,474,560       1,690,958  
Credit loss expense               17,917  
(Gain) loss on disposal of assets         (60,855 )     (124,610 )
Deferred income tax expense (benefit)   (12,242,582 )     (3,650,179 )     2,805,346  
Excess tax expense (benefit) related to share-based compensation   158,582       (201,533 )     99,437  
(Gain) loss on derivative contracts   82,230,925       (17,495,270 )     928,790  
Cash received (paid) for derivative settlements, net   (5,276,011 )     2,741,821       (553,594 )
Changes in operating assets and liabilities:          
Accounts receivable   (14,069,612 )     2,153,443       (564,158 )
Inventory   (836,248 )     (327,355 )     747,064  
Prepaid expenses and other assets   396,255       454,986       624,812  
Accounts payable   10,221,636       12,513,783       (10,385,137 )
Settlement of asset retirement obligation   (203,419 )     (67,428 )     (207,580 )
Net Cash Provided by Operating Activities   25,894,701       44,688,823       28,371,008  
           
Cash Flows From Investing Activities          
Payments for the Lime Rock Acquisition         (9,293,884 )     (70,859,769 )
Payments to purchase oil and natural gas properties   (2,781,731 )     (1,016,517 )     (647,106 )
Payments to develop oil and natural gas properties   (32,506,820 )     (24,955,052 )     (31,083,507 )
Payments to acquire or improve fixed assets subject to depreciation         (4,402 )     (34,275 )
Proceeds from sale of fixed assets subject to depreciation               17,360  
Proceeds from divestiture of oil and natural gas properties   4,266,479              
Net Cash Used in Investing Activities   (31,022,072 )     (35,269,855 )     (102,607,297 )
           
Cash Flows From Financing Activities          
Proceeds from revolving line of credit   48,000,000       30,500,000       114,000,000  
Payments on revolving line of credit   (42,000,000 )     (38,500,000 )     (39,000,000 )
Payments for taxes withheld on vested restricted shares, net   (965 )     (228,359 )     (896,431 )
Payments on notes payable   (505,752 )     (496,077 )     (496,397 )
Payment of deferred financing costs   (35,460 )     66,871        
Reduction of financing lease liabilities   (192,729 )     (145,397 )     (136,427 )
Net Cash Provided by (Used in) Financing Activities   5,265,094       (8,802,962 )     73,470,745  
           
Net Increase (Decrease) in Cash   137,723       616,006       (765,544 )
Cash at Beginning of Period   902,913       286,907       1,866,395  
Cash at End of Period $ 1,040,636     $ 902,913     $ 1,100,851  



RING ENERGY, INC.


Financial Commodity Derivative Positions

As of
May 5, 2026

The following tables reflect the details of current derivative contracts as of May 5, 2026 (quantities are in barrels (Bbl) for the oil derivative contracts and in million British thermal units (MMBtu) for the natural gas derivative contracts):

Oil Hedges (WTI) Q2 2026   Q3 2026   Q4 2026   Q1 2027   Q2 2027   Q3 2027   Q4 2027   Q1 2028
                               
Swaps:                              
Hedged volume (Bbl)   622,601     263,400     529,000     509,500     492,000     432,000     412,963    
Weighted average swap price $ 66.43   $ 61.77   $ 65.34   $ 62.82   $ 60.45   $ 61.80   $ 57.59   $
                               
Two-way collars:                              
Hedged volume (Bbl)   273,000     563,685     368,000                     400,080
Weighted average put price $ 55.00   $ 60.82   $ 65.00   $   $   $   $   $ 55.45
Weighted average call price $ 65.65   $ 76.19   $ 105.65   $   $   $   $   $ 65.45
                               
Swaps: WTI NYMEX Rolls                              
Hedged volume (BBL)   819,000     828,000                        
Weighted average swap price $ 5.30   $ 5.98   $   $   $   $   $   $

Gas Hedges (Henry Hub) Q2 2026   Q3 2026   Q4 2026   Q1 2027   Q2 2027   Q3 2027   Q4 2027   Q1 2028
                               
NYMEX Swaps:                              
Hedged volume (MMBtu)   1,165,628     600,016     1,072,305     439,678     423,035     1,079,906     1,046,151     1,012,567
Weighted average swap price $ 3.82   $ 4.19   $ 3.99   $ 4.02   $ 4.02   $ 3.86   $ 4.02   $ 3.77
                               
Two-way collars:                              
Hedged volume (MMBtu)   139,000     648,728     128,000     717,000     694,000            
Weighted average put price $ 3.50   $ 3.10   $ 3.50   $ 3.99   $ 3.00   $   $   $
Weighted average call price $ 5.42   $ 4.24   $ 5.42   $ 5.21   $ 4.32   $   $   $

Gas Hedges (Henry Hub) Q2 2028   Q3 2028   Q4 2028   Q1 2029   Q2 2029   Q3 2029   Q4 2029
                           
NYMEX Swaps:                          
Hedged volume (MMBtu)   984,322     956,865     931,539     908,117     886,933     866,585     846,134
Weighted average swap price $ 3.77   $ 3.77   $ 3.77   $ 3.67   $ 3.67   $ 3.67   $ 3.67

Gas Hedges (basis differential) Q2 2026   Q3 2026   Q4 2026   Q1 2027   Q2 2027   Q3 2027   Q4 2027   Q1 2028
                               
Waha basis swaps:                              
Hedged volume (MMBtu)           169,880     196,372     480,325     464,360     449,846     435,403
Weighted average spread price(1) $   $   $ 1.32   $ 0.78   $ 0.78   $ 0.78   $ 0.78   $ 0.68
                               
El Paso Permian Basin basis swaps:                              
Hedged volume (MMBtu)           225,184     960,307     636,710     615,547     596,306     577,163
Weighted average spread price(1) $   $   $ 1.35   $ 0.72   $ 0.67   $ 0.67   $ 0.67   $ 0.60


(1) The gas basis swap hedges are calculated as the Henry Hub natural gas price less the fixed amount specified as the weighted average spread price above.

RING ENERGY, INC.

Non-GAAP Financial Information

Certain financial information included in this release are not measures of financial performance recognized by accounting principles generally accepted in the United States (“GAAP”). These non-GAAP financial measures are “Adjusted Net Income,” “Adjusted EBITDA,” “Adjusted Free Cash Flow” or “AFCF,” “Adjusted Cash Flow from Operations” or “ACFFO,” “G&A Excluding Share-Based Compensation,” “G&A Excluding Share-Based Compensation and Transaction Costs,” “Leverage Ratio,” “All-In Cash Operating Costs,” and “Cash Operating Margin.” Management uses these non-GAAP financial measures in its analysis of performance. These disclosures may not be viewed as a substitute for results determined in accordance with GAAP and are not necessarily comparable to non-GAAP performance measures which may be reported by other companies.

Reconciliation of
Net income (loss)
to
Adjusted Net Income

“Adjusted Net Income” is calculated as net income (loss) minus the estimated after-tax impact of share-based compensation, ceiling test impairment, unrealized gains and losses on changes in the fair value of derivatives, and transaction costs for acquisitions and divestitures (“A&D”). Adjusted Net Income is presented because the timing and amount of these items cannot be reasonably estimated and affect the comparability of operating results from period to period, and current period to prior periods. The Company believes that the presentation of Adjusted Net Income provides useful information to investors as it is one of the metrics management uses to assess the Company’s ongoing operating and financial performance, and also is a useful metric for investors to compare the Company’s results with its peers.  

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026       2025       2025  
  Total   Per share – diluted   Total   Per share – diluted   Total   Per share – diluted
Net income (loss) $ (220,591,482 )   $ (1.06 )   $ (12,845,294 )   $ (0.06 )   $ 9,110,738     $ 0.05  
                       
Share-based compensation   1,524,808       0.01       1,474,560       0.01       1,690,958       0.01  
Ceiling test impairment   162,086,257       0.78       35,913,116       0.17              
Unrealized loss (gain) on change in fair value of derivatives   76,954,914       0.37       (14,753,449 )     (0.07 )     375,196        
Transaction costs – A&D               25,000             1,776        
Tax impact on adjusted items   (12,557,544 )     (0.06 )     (6,213,517 )     (0.03 )     (500,646 )     (0.01 )
                       
Adjusted Net Income $ 7,416,953     $ 0.04     $ 3,600,416     $ 0.02     $ 10,678,022     $ 0.05  
                       
Diluted Weighted-Average Shares Outstanding   208,558,546           207,233,067           201,072,594      
                       
Adjusted Net Income per Diluted Share $ 0.04         $ 0.02         $ 0.05      



Reconciliation of

Net income (loss)
to Adjusted EBITDA

The Company defines “Adjusted EBITDA” as net income (loss) plus net interest expense (including interest income and expense), unrealized loss (gain) on change in fair value of derivatives, ceiling test impairment, income tax (benefit) expense, depreciation, depletion and amortization, asset retirement obligation accretion, transaction costs for acquisitions and divestitures (A&D), share-based compensation, loss (gain) on disposal of assets, and backing out the effect of other income. Company management believes Adjusted EBITDA is relevant and useful because it helps investors understand Ring’s operating performance and makes it easier to compare its results with those of other companies that have different financing, capital and tax structures. Adjusted EBITDA should not be considered in isolation from or as a substitute for net income, as an indication of operating performance or cash flows from operating activities or as a measure of liquidity. Adjusted EBITDA, as Ring calculates it, may not be comparable to Adjusted EBITDA measures reported by other companies. In addition, Adjusted EBITDA does not represent funds available for discretionary use.

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026       2025       2025  
Net income (loss) $ (220,591,482 )   $ (12,845,294 )   $ 9,110,738  
           
Interest expense, net   8,529,080       9,065,509       9,408,728  
Unrealized loss (gain) on change in fair value of derivatives   76,954,914       (14,753,449 )     375,196  
Ceiling test impairment   162,086,257       35,913,116        
Income tax (benefit) expense   (11,988,413 )     (3,800,401 )     3,041,177  
Depreciation, depletion and amortization   21,405,948       23,002,908       22,615,983  
Asset retirement obligation accretion   395,496       390,892       326,549  
Transaction costs – A&D         25,000       1,776  
Share-based compensation   1,524,808       1,474,560       1,690,958  
Loss (gain) on disposal of assets         (60,855 )     (124,610 )
Other income   (5,837 )     (29,582 )     (8,942 )
           
Adjusted EBITDA $ 38,310,771     $ 38,382,404     $ 46,437,553  
           
Adjusted EBITDA Margin   52 %     57 %     59 %



Reconciliations of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow and Adjusted EBITDA to Adjusted Free Cash Flow

The Company defines “Adjusted Free Cash Flow” or “AFCF” as Net Cash Provided by Operating Activities (as reflected on the Company’s Condensed Statements of Cash Flows) less changes in operating assets and liabilities, and plus transaction costs for acquisitions and divestitures (“A&D”), current income tax expense (benefit), proceeds from divestitures of equipment for oil and natural gas properties, loss (gain) on disposal of assets, and less capital expenditures, credit loss expense, and other income. For this purpose, the Company’s definition of capital expenditures includes costs incurred related to oil and natural gas properties (such as drilling and infrastructure costs and lease maintenance costs) but excludes acquisition costs of oil and gas properties from third parties that are not included in the Company’s capital expenditures guidance provided to investors. Management believes that Adjusted Free Cash Flow is an important financial performance measure for use in evaluating the performance and efficiency of the Company’s current operating activities after the impact of capital expenditures and net interest expense (including interest income and expense, excluding amortization of deferred financing costs) and without being impacted by items such as changes associated with working capital, which can vary substantially from one period to another. Other companies may use different definitions of Adjusted Free Cash Flow.

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026       2025       2025  
           
Net Cash Provided by Operating Activities $ 25,894,701     $ 44,688,823     $ 28,371,008  
Adjustments – Condensed Statements of Cash Flows          
Changes in operating assets and liabilities   4,491,388       (14,727,429 )     9,784,999  
Transaction costs – A&D         25,000       1,776  
Income tax expense (benefit) – current   95,587       51,311       136,394  
Capital expenditures   (34,505,509 )     (24,343,200 )     (32,451,531 )
Proceeds from divestiture of oil and natural gas properties   4,266,479              
Credit loss expense               (17,917 )
Other income   (5,837 )     (29,582 )     (8,942 )
           
Adjusted Free Cash Flow $ 236,809     $ 5,664,923     $ 5,815,787  

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026       2025       2025  
           
Adjusted EBITDA $ 38,310,771     $ 38,382,404     $ 46,437,553  
           
Net interest expense (excluding amortization of deferred financing costs)   (7,834,932 )     (8,374,281 )     (8,170,235 )
Capital expenditures   (34,505,509 )     (24,343,200 )     (32,451,531 )
Proceeds from divestiture of oil and natural gas properties   4,266,479              
           
Adjusted Free Cash Flow $ 236,809     $ 5,664,923     $ 5,815,787  



Reconciliation of Net Cash Provided by Operating Activities to Adjusted Cash Flow from Operations

The Company defines “Adjusted Cash Flow from Operations” or “ACFFO” as Net Cash Provided by Operating Activities, as reflected in the Company’s Condensed Statements of Cash Flows, less the changes in operating assets and liabilities, which includes accounts receivable, inventory, prepaid expenses and other assets, accounts payable, and settlement of asset retirement obligations, which are subject to variation due to the nature of the Company’s operations. Accordingly, the Company believes this financial performance measure is useful to investors because it is used often in its industry and allows investors to compare this metric to other companies in its peer group as well as the E&P sector.

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026     2025       2025
           
Net Cash Provided by Operating Activities $ 25,894,701   $ 44,688,823     $ 28,371,008
           
Changes in operating assets and liabilities   4,491,388     (14,727,429 )     9,784,999
           
Adjusted Cash Flow from Operations $ 30,386,089   $ 29,961,394     $ 38,156,007



Reconciliation of General and Administrative Expense (G&A) to G&A Excluding Share-Based Compensation and Transaction Costs

The following table presents a reconciliation of General and Administrative Expense (“G&A”), a GAAP measure, to G&A excluding share-based compensation, and G&A excluding share-based compensation and transaction costs for acquisitions and divestitures (A&D).

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026     2025     2025
           
General and administrative expense (G&A) $ 7,438,778   $ 8,030,310   $ 8,619,976
Shared-based compensation   1,524,808     1,474,560     1,690,958
G&A excluding share-based compensation $ 5,913,970   $ 6,555,750   $ 6,929,018
Transaction costs – A&D       25,000     1,776
G&A excluding share-based compensation and transaction costs $ 5,913,970   $ 6,530,750   $ 6,927,242



Calculation of Leverage Ratio

“Leverage” or the “Leverage Ratio” is calculated pursuant to the Company’s existing senior revolving credit facility and means as of any date, the ratio of (i) Consolidated Total Debt as of such date to (ii) Consolidated EBITDAX for the four consecutive fiscal quarters ending on or immediately prior to such date for which financial statements are required to have been delivered under the credit facility.

The Company defines “Consolidated Total Debt” in accordance with its existing senior revolving credit facility and means, as of any date, all Indebtedness of the Company on a consolidated basis as of such date, but excluding hedging obligations.

The Company defines “Indebtedness” in accordance with its existing senior revolving credit facility and generally means (i) all obligations of the Company for borrowed money, (ii) all obligations of the Company evidenced by notes or other similar instruments, (iii) all obligations of the Company in respect of the deferred purchase price of property or services, (iv) all obligations of the Company under any conditional sale relating to property acquired the Company, (v) all capital lease obligations of the Company, (vi) all obligations, contingent or otherwise, of the Company in respect of letters of credit or similar extensions of credit, (vii) all guarantees of the Company of the type of Indebtedness described in clauses (i) through (vi) above, (viii) all Indebtedness of a third party secured by any lien on property owned by the Company, whether or not such Indebtedness has been assumed by the Company, (ix) all off-balance sheet liabilities, (x) all hedging obligations and (xi) the undischarged balance of any production payment created by the Company or for the creation of which the Company directly or indirectly received payment.

The Company defines “Consolidated EBITDAX” in accordance with its existing senior revolving credit facility and means for any period an amount equal to the sum of (i) consolidated net income (loss) for such period plus (ii) to the extent deducted in determining consolidated net income (loss) for such period, and without duplication, (A) consolidated interest expense, (B) income tax expense (benefit) determined on a consolidated basis, (C) depreciation, depletion and amortization determined on a consolidated basis, (D) exploration expenses determined on a consolidated basis, and (E) all other non-cash charges reasonably acceptable to the administrative agent, in each case for such period minus (iii) all noncash income added to consolidated net income (loss) for such period; provided that, for purposes of calculating compliance with the financial covenants under the credit facility, to the extent that during such period the Company has consummated an acquisition permitted by the credit facility or any sale, transfer or other disposition of any property or assets permitted by the credit facility, Consolidated EBITDAX will be calculated on a pro forma basis with respect to the property or assets acquired or disposed of.

The maximum permitted Leverage Ratio under the senior revolving credit facility is 3.00. The following tables show the leverage ratio calculations for the quarters ended March 31, 2026 and March 31, 2025.

  (Unaudited)
  Three Months Ended    
  June 30,   September 30,   December 31,   March 31,   Last Four Quarters

    2025       2025       2025       2026    
Consolidated EBITDAX Calculation:                  
Net Income (Loss) $ 20,634,887     $ (51,631,530 )   $ (12,845,294 )   $ (220,591,482 )   $ (264,433,419 )
Plus: Consolidated interest expense   11,687,746       9,978,067       9,065,509       8,529,080       39,260,402  
Plus: Income tax provision (benefit)   6,107,425       (12,800,947 )     (3,800,401 )     (11,988,413 )     (22,482,336 )
Plus: Depreciation, depletion and amortization   25,569,914       25,225,345       23,002,908       21,405,948       95,204,115  
Plus: non-cash charges reasonably acceptable to Administrative Agent   (12,236,121 )     77,063,418       23,025,119       240,961,475       328,813,891  
Consolidated EBITDAX $ 51,763,851     $ 47,834,353     $ 38,447,841     $ 38,316,608     $ 176,362,653  
Plus: Pro Forma Acquired Consolidated EBITDAX                            
Less: Pro Forma Divested Consolidated EBITDAX                            
Pro Forma Consolidated EBITDAX $ 51,763,851     $ 47,834,353     $ 38,447,841     $ 38,316,608     $ 176,362,653  
                   
Non-cash charges reasonably acceptable to Administrative Agent:                  
Asset retirement obligation accretion $ 382,251     $ 390,563     $ 390,892     $ 395,496      
Unrealized loss (gain) on derivative assets   (13,970,211 )     2,141,925       (14,753,449 )     76,954,914      
Ceiling test impairment         72,912,330       35,913,116       162,086,257      
Share-based compensation   1,351,839       1,618,600       1,474,560       1,524,808      
Total non-cash charges reasonably acceptable to Administrative Agent $ (12,236,121 )   $ 77,063,418     $ 23,025,119     $ 240,961,475      
                   
  As of                
  March 31,   Corresponding            
    2026     Leverage Ratio            
Leverage Ratio Covenant:                  
Revolving line of credit $ 426,000,000       2.42              
Notes payable                      
Deferred payment                      
Capital lease obligations $ 1,173,807                    
Consolidated Total Debt $ 427,173,807       2.42              
Pro Forma Consolidated EBITDAX   176,362,653                  
Leverage Ratio   2.42                  
Maximum Allowed ≤ 3.00x                

  (Unaudited)
  Three Months Ended    
  June 30,   September 30,   December 31,   March 31,   Last Four Quarters

    2024       2024       2024     2025  
Consolidated EBITDAX Calculation:                  
Net Income (Loss) $ 22,418,994     $ 33,878,424     $ 5,657,519   $ 9,110,738   $ 71,065,675  
Plus: Consolidated interest expense   10,801,194       10,610,539       9,987,731     9,408,728     40,808,192  
Plus: Income tax provision (benefit)   6,820,485       10,087,954       1,803,629     3,041,177     21,753,245  
Plus: Depreciation, depletion and amortization   24,699,421       25,662,123       24,548,849     22,615,983     97,526,376  
Plus: non-cash charges acceptable to Administrative Agent   1,664,064       (26,228,108 )     8,994,957     2,392,703     (13,176,384 )
Consolidated EBITDAX $ 66,404,158     $ 54,010,932     $ 50,992,685   $ 46,569,329   $ 217,977,104  
Plus: Pro Forma Acquired Consolidated EBITDAX   10,329,116       7,838,163       5,244,078     7,392,359     30,803,716  
Less: Pro Forma Divested Consolidated EBITDAX   (469,376 )     (600,460 )     77,819     8,855     (983,162 )
Pro Forma Consolidated EBITDAX $ 76,263,898     $ 61,248,635     $ 56,314,582   $ 53,970,543   $ 247,797,658  
                   
Non-cash charges acceptable to Administrative Agent:                  
Asset retirement obligation accretion $ 352,184     $ 354,195     $ 323,085   $ 326,549    
Unrealized loss (gain) on derivative assets   (765,898 )     (26,614,390 )     6,999,552     375,196    
Share-based compensation   2,077,778       32,087       1,672,320     1,690,958    
Total non-cash charges acceptable to Administrative Agent $ 1,664,064     $ (26,228,108 )   $ 8,994,957   $ 2,392,703    
                   
  As of                
  March 31,   Corresponding            
    2025     Leverage Ratio            
Leverage Ratio Covenant:                  
Revolving line of credit $ 460,000,000       1.86              
Lime Rock deferred payment   10,000,000       0.04              
Consolidated Total Debt $ 470,000,000       1.90              
Pro Forma Consolidated EBITDAX   247,797,658                  
Leverage Ratio   1.90                  
Maximum Allowed ≤ 3.00x                



All-In Cash Operating Costs

The Company defines All-In Cash Operating Costs, a non-GAAP financial measure, as “all in cash” costs which includes lease operating expenses, G&A costs excluding share-based compensation, net interest expense (including interest income and expense, excluding amortization of deferred financing costs), workovers and other operating expenses, production taxes, ad valorem taxes, and gathering/transportation costs. Management believes that this metric provides useful additional information to investors to assess the Company’s operating costs in comparison to its peers, which may vary from company to company.

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026     2025     2025
All-In Cash Operating Costs:          
Lease operating expenses (including workovers) $ 18,122,344   $ 18,911,801   $ 19,677,552
G&A excluding share-based compensation   5,913,970     6,555,750     6,929,018
Net interest expense (excluding amortization of deferred financing costs)   7,834,932     8,374,281     8,170,235
Operating lease expense   175,091     175,090     175,091
Oil and natural gas production taxes   3,553,891     3,224,183     3,584,455
Ad valorem taxes   2,202,537     2,279,266     1,532,108
Gathering, transportation and processing costs   117,049     121,097     203,612
All-in cash operating costs $ 37,919,814   $ 39,641,468   $ 40,272,071
           
Boe   1,741,581     1,886,755     1,655,259
           
All-in cash operating costs per Boe $ 21.77   $ 21.01   $ 24.33



Cash Operating Margin

The Company defines Cash Operating Margin, a non-GAAP financial measure, as realized revenues per Boe less “all-in cash operating costs” per Boe. Management believes that this metric provides useful additional information to investors to assess the Company’s operating margins in comparison to its peers, which may vary from company to company.

  (Unaudited for All Periods)
  Three Months Ended
  March 31,   December 31,   March 31,
    2026     2025     2025
Cash Operating Margin          
Realized revenues per Boe $ 42.30   $ 35.45   $ 47.78
All-in cash operating costs per Boe   21.77     21.01     24.33
Cash Operating Margin per Boe $ 20.53   $ 14.44   $ 23.45



Nutrien Declares Quarterly Dividend of US$0.55 per Share

Nutrien Declares Quarterly Dividend of US$0.55 per Share

SASKATOON, Saskatchewan–(BUSINESS WIRE)–
Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.55 per share payable on July 17, 2026, to shareholders of record on June 30, 2026.

Registered shareholders who are residents of Canada as reflected in Nutrien’s shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on June 30, 2026. Registered shareholders resident outside of Canada as reflected in Nutrien’s shareholders register, including the United States, as well as beneficial holders whose intermediary is a participant in The Depository Trust Company or its nominee, Cede & Co., will receive their dividend in US dollars. However, registered shareholders of Nutrien may elect to change the currency of their dividend payments to US dollars or Canadian dollars, as applicable. In addition, Nutrien offers registered shareholders direct deposit by electronic funds transfer for dividend payments.

Registered shareholders may elect to change the currency of their dividend and enroll for direct deposit by contacting Nutrien’s registrar and transfer agent, Computershare Investor Services Inc., directly (1-800-564-6253 or [email protected]). Beneficial shareholders should contact their broker or other intermediary to determine the ability and necessary steps involved in an election to change the currency of their dividend payment. For further details, please visit www.nutrien.com/investors/nutrien-historical-dividend.

All dividends paid by Nutrien are, pursuant to subsection 89(14) of the Income Tax Act (Canada), designated as eligible dividends.

About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

FOR FURTHER INFORMATION:


Investor Contact

Jeff Holzman

Senior Vice President, Investor Relations and FP&A

(306) 933 8545 – [email protected]

Media Contact

Simon Scott

Vice President, Global Communications

(403) 225 7213 – [email protected]

Contact us at: www.nutrien.com

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Agriculture Natural Resources

MEDIA:

Logo
Logo

Newell Brands Declares Dividend on Common Stock

Newell Brands Declares Dividend on Common Stock

ATLANTA–(BUSINESS WIRE)–
Newell Brands Inc. (NASDAQ: NWL) announced today the declaration of a quarterly cash dividend of $0.07 per share. The dividend is payable June 15, 2026 to common stockholders of record at the close of trading on May 29, 2026.

About Newell Brands

Newell Brands (NASDAQ: NWL) is a leading global consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer’s, Oster, NUK, Spontex and Campingaz. Newell Brands is focused on delighting consumers by lighting up everyday moments.

This press release and additional information about Newell Brands are available on the company’s website, www.newellbrands.com.

Investors:

Joanne Freiberger

SVP, Investor Relations & Chief Communications Officer

+1 (727) 947-0891

[email protected]

Media:

Danielle Clark

Director, External Communications

+1 (404) 783-0419

[email protected]

 

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: Home Goods Retail Office Products

MEDIA:

Logo
Logo

Equinox Gold Declares Quarterly Cash Dividend of US$0.015 per Common Share

VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) — Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox Gold” or the “Company”) is pleased to announce that its Board of Directors (“Board”) has declared a quarterly cash dividend of US$0.015 per common share of the Company, payable on June 5, 2026 to shareholders of record as at the close of business on the record date of May 21, 2026.

The dividend is designated as an “eligible dividend” for Canadian income tax purposes.

The declaration, amount, and payment of future dividends remain subject to the discretion of the Board and will depend upon the Company’s financial results, capital requirements, business conditions, compliance with applicable legal and debt covenant requirements and other factors considered relevant. The Company will review its dividend policy on an ongoing basis and may amend it at any time.

Equinox Gold Contact

Ryan King

EVP Capital Markets
T: 778.998.3700
E: [email protected]
E: [email protected]


Cautionary Notes & Forward-looking Statements


This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation and may include future-oriented financial information or financial outlook information (collectively “Forward-looking Information”). Forward-looking Information in this news release relates to planned dividend payments. Forward-looking Information is generally identified by words such as “will”, “future”, and similar expressions, or statements that actions, events or results “may”, “could” or “should” occur. Although the Company believes the expectations reflected in the Forward-looking Information are reasonable , readers are cautioned not to put undue reliance on Forward-looking Information as actual results may differ materially. Forward-looking Information in this news release is based on the Company’s current expectations and projections about future events and these assumptions include: Equinox Gold’s ability to achieve the production, cost and development expectations for its respective operations and projects; prices for gold remaining as estimated; and availability of funds for the Company’s projects and future cash requirements, including for any dividend. While the Company considers these assumptions to be reasonable based on information currently available, they may prove to be incorrect. Forward-looking Information involves numerous risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied. These factors include those described under “Risk Factors” in the Company’s most recent MD&A and “Risks Related to the Business” in Equinox Gold’s most recently filed Annual Information Form, each available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov/edgar. Forward-Looking Information reflects management’s current expectations and assumptions and is subject to change. Except as required by applicable law, the Company undertakes no obligation to update or publicly revise any Forward-Looking Information, whether because of new information, future events or otherwise. No inference should be drawn from any update that the Company will make further updates. All Forward-Looking Information in this news release is expressly qualified by this cautionary statement.



Endeavour Silver Announces Q1 2026 Financial Results

VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) — Endeavour Silver Corp.
(“Endeavour” or the “Company”)
(NYSE: EXK; TSX: EDR) announces its financial and operating results for the three months ended March 31, 2026. The Company will host a conference call to discuss these results on Thursday, May 7 at 10:00am PT/1:00pm EDT; details are provided further in this news release. All dollar amounts are in US dollars ($).

“Endeavour delivered exceptional results in the first quarter of 2026, with increased production driving strong quarterly growth,” said Dan Dickson, Chief Executive Officer. “We reached new records in both production and revenue, underscoring the strength of our operations, the dedication of our team and the benefit of robust silver and gold prices. The Company’s operating cash flow also saw significant growth.”

“With a solid financial foundation and the successful completion of the Kolpa plant expansion and Terronera operating near design criteria, Endeavour is well positioned to achieve its production goals for the remainder of the year. These results highlight our commitment to operational excellence while creating lasting value for our shareholders.”


Q1 2026 Highlights

  • Higher Production Fuels Quarterly Growth: Consolidated production of 1,875,375 ounces (“oz”) Silver and 11,740 oz Gold for 3.3 million oz silver equivalent (“AgEq”)(1). Production was 78% higher than the same period in 2025.   
  • Record Ounces Sold with Record Realized Prices: $209.7 million from the sale of 1,642,220 oz of silver and 10,942 oz of gold at average realized prices of $85.95 per oz silver and $5,035 per oz gold as well as from sales of base metals. Revenue is 230% higher than in the same period in 2025.
  • Strong Mine Operating Cash Flow: $114.6 million in mine operating cash flow before taxes(2), 419% higher than the same period in 2025.
  • Steady Operating Costs: Cash costs(2) of $22.54 per oz payable silver and all-in sustaining costs(2) of $37.03 per oz, net of by-product credits compared to $19.05 and $41.19, respectively, in Q4 2025.
  • Strong Cash Position
    : $231.8 million in cash as of March 31, 2026.
  • Higher Production Capacity: Plant expansion at Kolpa has been completed with throughput expected to be in line with guidance for the remainder of 2026.
  • Bolañitos Sale Finalized: On January 15, 2026, the Company completed the sale of the Bolañitos silver and gold mine (see news release from January 15, 2026 here) and made a gain on the sale of $35.6 million. The Bolañitos results for the first 15 days of 2026 are included in the Company’s financial results.


Financial Overview

Q1 2026 Highlights Three Months Ended March 31
2026 2025
% Change
Production      
Silver ounces produced 1,875,375 1,205,793 56%
Gold ounces produced 11,740 8,338 41%
Lead tonnes produced 4,939
Zinc tonnes produced 2,842
Silver equivalent ounces produced(1) 3,341,943 1,872,833 78%
Cash costs per silver ounce ($)(2) 22.54 15.89 42%
Total production costs per ounce ($)(2) 35.21 24.23 45%
All-in sustaining costs per ounce ($)(2) 37.03 24.48 51%
Processed tonnes 456,657 209,507 118%
Direct operating costs per tonne ($)(2) 186.92 142.72 31%
Direct costs per tonne ($)(2) 256.33 207.27 24%
Financial      
Revenue ($ millions) 209.7 63.5 230%
Silver ounces sold 1,642,220 1,223,684 34%
Gold ounces sold 10,942 8,538 28%
Realized silver price per ounce ($) 85.95 31.99 169%
Realized gold price per ounce ($) 5,035 2,903 73%
Net earnings (loss) ($ millions) 64.9 (32.9) 297%
Adjusted net earnings (loss)(2) ($ millions) 59.2 (0.2) 28861%
Mine operating earnings ($ millions) 93.5 12.8 628%
Mine operating cash flow before taxes ($ millions)(2) 114.6 22.1 419%
Operating cash flow before working capital changes ($ millions)(2) 38.8 8.3 365%
EBITDA ($ millions)(2) 112.6 (18.1) 722%
Adjusted EBITDA ($ millions)(2) 108.4 15.1 617%
Working capital ($ millions)(2) 173.4 14.8 1071%
Shareholders      
Earnings (loss) per share – basic ($) 0.23 (0.13) 277%
Adjusted earnings (loss) per share – basic ($)(2) 0.21 100%
Operating cash flow before working capital changes per share ($)(2) 0.14 0.03 367%
Basic weighted average shares outstanding (‘000) 283,078 262,323 8%
       

(1) Silver equivalents for 2026 are calculated using a 90:1 Ag:Au ratio, 45 silver oz to 1 lead tonne; 61 silver oz to 1 zinc tonne; 238 silver oz to 1 copper tonne ratio. Silver equivalents for 2025 are calculated using an 80:1 Ag:Au ratio, 60 silver oz to 1 lead tonne; 85 silver oz to 1 zinc tonne; 300 silver oz to 1 copper tonne ratio.
(2) These are non-IFRS financial measures and ratios. Further details on these non-IFRS financial measures and ratios are provided at the end of this press release and in the MD&A accompanying the Company’s financial statements, which can be viewed on the Company’s website, on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov.

Direct operating costs per tonne in Q1 2026 increased to $186.92, 31% higher than $142.72 in Q1 2025. The increase was primarily driven by the addition of Terronera and Kolpa, which had direct operating costs per tonne of $195.11 and $155.92, respectively, during Q1 2026. The disposal of Bolañitos, which had a lower direct operating cost per tonne of $102.81 in Q1 2025, also contributed to the higher consolidated average. In addition, Guanaceví experienced higher cost per tonne due to lower throughput and higher underlying direct production costs.

Consolidated cash costs per silver ounce, net of by-product credits, were $22.54 in Q1 2026, representing a 42% increase from $15.89 in Q1 2025 due to the higher metal prices causing higher royalty, third party material cost, and special mining duties. Each mine has different costs and produces different amounts of payable silver, which affect the consolidated cash cost per ounce depending on the mix of production. For the three months ended March 31, 2026, the cash costs per silver ounce were $24.52 for Kolpa, $38.59 for Guanaceví, offset by negative $2.14 for Terronera.

Consolidated All‑in Sustaining Costs (“AISC”) per silver ounce in Q1 2026 were $37.03, 51% higher than $24.48 in Q1 2025. The increase was predominantly due to the contribution of Kolpa, which had AISC of $36.12 per ounce, and higher AISC of $48.47 at Guanaceví caused by the higher third-party material cost, higher royalties and special mining duties, partially offset by the contribution from Terronera, where AISC of $22.31 per ounce lowered the consolidated average. Consolidated AISC decreased from $41.19 in Q4 2025 to $37.03 in Q1 2026 primarily reflecting the ramp up of operations at Terronera and the efficiencies gained.

In Q1 2026, the Company’s mine operating earnings were $93.5 million (Q1 2025 – $12.9 million), driven by operating earnings of $38.4 million from Terronera, $23.0 million from Kolpa, and $20.4 million higher operating earnings at Guanaceví, partially offset by lower operating earnings from Bolañitos following its sale on January 15, 2026. Revenue for the quarter was $209.7 million, compared to $63.5 million in Q1 2025 driven by higher metal prices and higher sales, while cost of sales increased to $116.3 million from $50.6 million, primarily due to the inclusion of revenue and costs incurred at Terronera and Kolpa.

The Company recorded operating earnings of $83.8 million in Q1 2026 (Q1 2025 – $4.1 million) after exploration expenditures of $5.0 million (Q1 2025 – $4.5 million) and general and administrative expenses of $4.7 million (Q1 2025 – $4.3 million). Exploration expenses increased due to additional expenditures on advancing Pitarrilla and exploration work at Kolpa, partially offset by lower exploration spending at Terronera.

Earnings before taxes for Q1 2026 were $85.9 million, compared to a loss of $27.7 million in Q1 2025. This was after a loss on derivative contract revaluations of $24.2 million, a foreign exchange loss of $0.3 million, investment and other income loss of $3.2 million, and finance costs of $5.8 million, partially offset by a gain on the sale of Bolañitos of $35.6 million.

The Company recorded net earnings of $64.9 million for Q1 2026 (Q1 2025 – net loss of $32.9 million) after income tax expense of $21.0 million, which included $33.8 million of current tax expense and a deferred tax recovery of $12.8 million, primarily arising from temporary differences related to the buildup of finished goods inventory.

This news release should be read in conjunction with the Company’s condensed consolidated interim financial statements for the period ended March 31, 2026, and associated Management’s Discussion and Analysis (“MD&A”) which are available on the Company’s website, www.edrsilver.com, on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov.

About Endeavour Silver – Endeavour is a mid-tier silver producer with three operating mines in Mexico and Peru and a robust pipeline of exploration projects across Mexico, Chile, and the United States. With a proven track record of discovery, development, and responsible mining, Endeavour is driving organic growth and creating lasting value on its path to becoming a leading senior silver producer.


Conference Call

Management will host a conference call to discuss the Company’s Q1 2026 financial results on May 7 at 10:00am Pacific (PT)/ 1:00pm Eastern (EDT).

Date: Thursday, May 7, 2026
   
Time: 10:00am Pacific Time / 1:00pm Eastern Daylight Time
   
Telephone: Canada & US +1-833-752-3348
  International +1-647-846-2804
   
Replay: Canada/US Toll Free +1-855-669-9658
  International +1-412-317-0088
  Access code is 7015869; audio replay will be available on the Company’s website
   

Contact Information

Allison Pettit
Vice President, Investor Relations
Email: [email protected]
Website: www.edrsilver.com


Endnotes

1
Silver equivalent (AgEq)

Silver equivalents for 2026 are calculated using a 90:1 Ag:Au ratio, 45 silver oz to 1 lead tonne; 61 silver oz to 1 zinc tonne; 238 silver oz to 1 copper tonne ratio. Silver equivalents for 2025 are calculated using an 80:1 Ag:Au ratio, 60 silver oz to 1 lead tonne; 85 silver oz to 1 zinc tonne; 300 silver oz to 1 copper tonne ratio.

2
Non-IFRS and Other Financial Measures and Ratios

Certain non-IFRS and other non-financial measures and ratios are included in this press release, including cash costs per silver ounce, total production costs per ounce, all-in costs per ounce, AISC per ounce, direct operating costs per tonne, direct costs per tonne, silver co-product cash costs, gold co-product cash costs, realized silver price per ounce, realized gold price per ounce, adjusted net earnings (loss) adjusted net earnings (loss) per share, mine operating cash flow before taxes, working capital, operating cash flow before working capital adjustments, operating cash flow before working capital changes per share, earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA per share, sustaining and growth capital and adjusted net earnings (loss).

Please see the March 31, 2026 MD&A for explanations and discussion of these non-IFRS and other non-financial measures and ratios. The Company believes that these measures and ratios, in addition to conventional measures and ratios prepared in accordance with International Financial Reporting Standards (“IFRS”), provide management and investors an improved ability to evaluate the underlying performance of the Company. The non-IFRS and other non-financial measures and ratios are intended to provide additional information and should not be considered in isolation or as a substitute for measures or ratios of performance prepared in accordance with IFRS. These measures and ratios do not have any standardized meaning prescribed under IFRS and therefore may not be comparable to other issuers. Certain additional disclosures for these non-IFRS measures have been incorporated by reference and can be found in the section “Non-IFRS Measures” in the March 31, 2026 MD&A available on SEDAR at www.sedarplus.com.

Reconciliation of Working Capital

Expressed in millions of U.S. dollars  As at March 31, 2026 As at December 31, 2025
         
Current assets   $422.9   $423.2
Current liabilities   249.5   276.8
Working capital surplus   $173.4   $146.4
         

Reconciliation of Adjusted Net Earnings (Loss) and Adjusted Net Earnings (Loss) Per Share

Expressed in
millions
of U.S. dollars
Three Months Ended March 31
(except for share numbers and per share amounts) 2026 2025
Net earnings (loss) for the period per financial statements $64.9 ($32.9)
Unrealized foreign exchange (gain) loss 0.6 0.3
(Gain) loss on derivatives copper stream and contingent liabilities revaluations 25.4 31.9
Gain from sale of Bolañitos (35.6)
Change in fair value of investments 4.1 (0.1)
Change in fair value of cash settled DSUs (0.1) 0.6
Adjusted net earnings (loss) $59.2 ($0.2)
Basic weighted average shares outstanding (‘000) 283,078 262,323
Adjusted net earnings (loss) per share $0.21 ($0.00)
     

Reconciliation of Mine Operating Cash Flow Before Taxes

Expressed in millions of U.S. dollars Three Months Ended March 31
  2026 2025
Mine operating earnings per financial statements $93.5 $12.8
Share-based compensation 0.2
Depreciation 20.9 9.2
Mine operating cash flow before taxes $114.6 $22.1
     

Reconciliation of Operating Cash Flow Before Working Capital Changes and Operating Cash Flow Before Working Capital Changes Per Share

Expressed in millions of U.S. dollars Three Months Ended March 31
(except for per share amounts) 2026 2025
Cash from (used in) operating activities per financial statements $20.7 $3.4
Net changes in non-cash working capital per financial statements (18.1) (5.0)
Operating cash flow before working capital changes $38.8 $8.3
Basic weighted average shares outstanding (‘000) 283,078 262,323
Operating cash flow before working capital changes per share $0.14 $0.03
     

Reconciliation of EBITDA and Adjusted EBITDA

Expressed in millions of U.S. dollars Three Months Ended March 31
  2026 2025
Net earnings (loss) for the period per financial statements $64.9 ($32.9)
Depreciation – cost of sales 20.9 9.2
Depreciation – exploration, evaluation and development 0.2 0.3
Depreciation – general & administration 0.1 0.1
Finance costs 5.6 0.2
Current income tax expense (recovery) 33.8 5.3
Deferred income tax expense (recovery) (12.8) (0.2)
EBITDA $112.6 ($18.1)
Share based compensation 1.4 0.5
Unrealized foreign exchange (Gain) loss 0.6 0.2
(Gain) loss on derivatives, copper stream and contingent liabilities revaluations 25.4 31.9
(Gain) loss from disposal of Bolañitos (35.6)
Change in fair value of investments 4.1 (0.1)
Change in fair value of cash settled DSUs (0.1) 0.6
Adjusted EBITDA $108.4 $15.1
Basic weighted average shares outstanding (‘000) 283,078 262,323
Adjusted EBITDA per share $0.38 $0.06
     

Reconciliation of Cash Cost Per Silver Ounce, Total Production Costs Per Ounce, Direct Operating Costs Per Tonne, Direct Costs Per Tonne

Expressed in millions of U.S. dollars Three Months Ended

March 31, 2026
Terronera Guanaceví Bolañitos Kolpa Total
Direct production costs per financial statements $33.8 $24.0 $1.7 $24.5 $83.9
Purchase of the third-party material (10.3) (0.9) (11.3)
Smelting and refining costs included in revenue 1.2 0.2 2.6 4.0
Opening finished goods (3.0) (8.6) (0.2) (0.8) (12.6)
Closing finished goods 2.2 17.6 1.4 21.3
Direct operating costs 34.2 22.8 1.6 26.8 85.4
Purchase of the third-party material 10.3 0.9 11.3
Royalties 2.4 7.1 1.6 11.2
Special mining duty (1) 4.4 3.5 0.2 1.2 9.2
Direct costs 41.0 43.7 1.8 30.5 117.1
By-products sales (42.5) (10.1) (2.5) (17.5) (72.6)
Opening by-products inventory fair market value 3.0 3.2 0.1 0.6 6.9
Closing by-products inventory fair market value (2.6) (6.4) (1.3) (10.4)
Cash costs net of by-products (1.1) 30.3 (0.6) 12.3 40.9
Depreciation 9.4 4.7 6.8 20.9
Share-based compensation 0.1 0.1 0.1 0.2
Opening finished goods depreciation (0.5) (1.8) (0.2) (2.4)
Closing finished goods depreciation 0.6 3.5 0.3 4.4
Total production costs $8.5 $36.7 $(0.6) $19.3 $63.9
           

Expressed in millions of U.S. dollars Three Months Ended

March 31, 2025
Terronera Guanaceví Bolañitos Kolpa Total
Direct production costs per financial statements $- $25.4 $9.7 $- $35.2
Purchase of the third-party material (5.9) (5.9)
Smelting and refining costs included in revenue 0.4 0.4
Opening finished goods (5.4) (0.5) (5.9)
Closing finished goods 4.8 1.3 6.1
Direct operating costs 18.9 11.0 29.9
Purchase of the third-party material 5.9 5.9
Royalties 6.1 0.2 6.2
Special mining duty (1) 1.0 0.4 1.4
Direct costs 31.8 11.6 43.4
By-products sales (12.8) (12.0) (24.8)
Opening by-products inventory fair market value 3.2 0.8 4.0
Closing by-products inventory fair market value (2.2) (1.4) (3.6)
Cash costs net of by-products 20.0 (1.0) 19.0
Depreciation 6.6 2.6 9.2
Share-based compensation 0.0 0.0 0.0
Opening finished goods depreciation (1.2) (0.1) (1.3)
Closing finished goods depreciation 1.6 0.4 2.0
Total production costs $- $27.0 $1.9 $- $28.9
           

(1)    Special mining duty is an EBITDA royalty tax presented as a current income tax in accordance with IFRS.

  Three Months Ended

March 31, 2026
Terronera Guanaceví Bolañitos Kolpa Total
Throughput tonnes 175,418 95,524 13,988 171,727 456,657
Payable silver ounces 510,521 785,494 17,668 501,458 1,815,142
           
Cash costs per silver ounce ($2.14) $38.59 ($34.70) $24.52 $22.54
Total production costs per ounce $16.67 $46.76 ($34.69) $38.43 $35.21
Direct operating costs per tonne $195.11 $238.30 $113.74 $155.92 $186.92
Direct costs per tonne $233.84 $457.23 $130.37 $177.82 $256.33
           

  Three Months Ended

March 31, 2025
Terronera Guanaceví Bolañitos Kolpa Total
Throughput tonnes 102,438 107,069 209,507
Payable silver ounces 1,012,281 181,077 1,193,358
           
Cash costs per silver ounce $- $19.73 ($5.60) $- $15.89
Total production costs per ounce $- $26.66 $10.65 $- $24.23
Direct operating costs per tonne $- $184.43 $102.81 $- $142.72
Direct costs per tonne $- $310.52 $108.49 $- $207.27
           

Expressed in millions of U.S. dollars March 31, 2026
Terronera Guanaceví Bolañitos Kolpa Total
Closing finished goods 2.2 17.6 1.4 21.3
Closing finished goods depreciation 0.6 3.5 0.3 4.4
Finished goods inventory $2.8 $21.1 $- $1.7 $25.7
           

Expressed in millions of U.S. dollars March 31, 2025
Terronera Guanaceví Bolañitos Kolpa Total
Closing finished goods 4.8 1.3 6.1
Closing finished goods depreciation 1.6 0.4 2.0
Finished goods inventory $- 6.4 1.7 $- 8.1
           

Reconciliation of All-In Costs Per Ounce and AISC per ounce

Expressed in millions of U.S. dollars Three Months Ended

March 31, 2026
Terronera Guanaceví Bolañitos Kolpa Total
Cash costs net of by-products ($1.1) $30.3 ($0.6) $12.3 $40.9
Operations share-based compensation 0.1 0.1 0.1 0.2
Corporate general and administrative 1.3 1.1 0.1 1.0 3.4
Corporate share-based compensation 0.5 0.4 0.3 1.2
Reclamation – amortization/accretion 0.1 0.1 0.3
Mine site expensed exploration 0.3 0.4 1.4 2.1
Equipment loan payments 0.9 0.2 1.1
Capital expenditures sustaining 9.3 5.7 0.2 2.9 18.1
All-In-Sustaining Costs $11.4 $38.1 ($0.4) $18.1 $67.2
Growth exploration, evaluation and development         2.7
Growth capital expenditures         5.8
All-In-Costs         $75.7
           

Expressed in millions of U.S. dollars Three Months Ended

March 31, 2025
Terronera Guanaceví Bolañitos Kolpa Total
Cash costs net of by-products $- $20.0 ($1.0) $- $19.0
Operations share-based compensation 0.0
Corporate general and administrative 2.7 1.1 3.8
Corporate share-based compensation 0.3 0.1 0.4
Reclamation – amortization/accretion 0.1 0.1 0.2
Mine site expensed exploration 0.3 0.2 0.4
Capital expenditures sustaining 3.4 1.9 5.4
All-In-Sustaining Costs $- $26.8 $2.4 $- $29.2
Growth exploration, evaluation and development         3.8
Growth capital expenditures         36.2
All-In-Costs         $69.2
           

  Three Months Ended

March 31, 2026
Terronera Guanaceví Bolañitos Kolpa Total
Throughput tonnes 175,418 95,524 13,988 171,727 456,657
Payable silver ounces 510,521 785,494 17,668 501,458 1,815,142
Silver equivalent production (ounces) 1,296,348 1,042,779 62,766 940,050 3,341,943
           
All-in-Sustaining cost per ounce $22.31 $48.47 ($20.22) $36.12 $37.03
           

  Three Months Ended

March 31, 2025
Terronera Guanaceví Bolañitos Kolpa Total
Throughput tonnes 102,438 107,069 209,507
Payable silver ounces 1,012,281 181,077 1,193,358
Silver equivalent production (ounces) 1,334,447 538,386 1,872,833
           
All-in-Sustaining cost per ounce $- $26.50 $13.16 $- $24.48
           

Reconciliation o
f Sustaining Capital and Growth Capital

Expressed in millions of U.S. dollars Three Months Ended March 31
2026 2025
Capital expenditures sustaining $18.1 $5.4
Growth capital expenditures 5.8 $36.2
Property, plant and equipment expenditures per financial statements $23.9 $41.6
     

Expressed in millions of U.S. dollars Three Months Ended March 31
2026 2025
Mine site expensed exploration $2.1 $0.4
Growth exploration, evaluation and development 2.7 3.8
Total exploration, evaluation and development 4.8 4.2
Exploration, evaluation and development depreciation 0.2 0.3
Exploration, evaluation and development share-based compensation 0.1 0.1
Exploration, evaluation and development expense $5.0 $4.5
     

Expressed in millions of U.S. dollars
Unless otherwise stated
Three Months Ended March 31
2026 2025
Gross silver sales $141.1 $39.2
Silver ounces sold 1,642,220 1,223,684
Realized silver price per ounce $85.95 $31.99
     

Expressed in millions of U.S. dollars
Unless otherwise stated
Three Months Ended March 31
2026   2025
Gross gold sales $55.1 $24.8
Gold ounces sold   10,942   8,538
Realized gold price per ounce $5,035 $2,903
     

Expressed in millions of U.S. dollars
Unless otherwise stated
Three Months Ended March 31
2026 2025
Gross lead sales $8.9 $-
Lead tonnes sold 4,542
Realized lead price per tonne $1,966 $-

Expressed in millions of U.S. dollars
Unless otherwise stated
Three Months Ended March 31
2026   2025
Gross zinc sales $7.0 $-
Zinc tonnes sold   2,295                         –
Realized zinc price per tonne $3,070 $-
     

Expressed in millions of U.S. dollars
Unless otherwise stated
Three Months Ended March 31
2026   2025
Gross copper sales $0.7 $-
Copper tonnes sold   55                         –
Realized copper price per tonne $12,909 $-
     


Cautionary Note Regarding Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of the United States private securities litigation reform act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking statements and information herein include but are not limited to statements regarding expected operating and efficiency improvements, the Company’s strategic objectives, areas of priority, ability to meet production goals, expectations of throughput at Kolpa, the planned allocation of resources, Endeavour’s ability to unlock value across the Company’s development pipeline and deliver long-term value for its stakeholders, and the timing and results of various activities. The Company does not intend to and does not assume any obligation to update such forward-looking statements or information, other than as required by applicable law.

Forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, production levels, performance or achievements of Endeavour and its operations to be materially different from those expressed or implied by such statements. Such factors include but are not limited to unexpected changes in production and costs guidance; the ongoing effects of inflation and supply chain issues on mine economics; fluctuations in the prices of silver and gold; fluctuations in the currency markets (particularly the Mexican peso, Peruvian sol, Canadian dollar, Chilean peso, and U.S. dollar); fluctuations in interest rates; effects of inflation; changes in national and local governments, legislation, taxation, controls, regulations and political or economic developments in Canada, Peru and Mexico; operating or technical difficulties in mineral exploration, development and mining activities; risks and hazards of mineral exploration, development and mining (including, but not limited to, environmental hazards, industrial accidents, unusual or unexpected geological conditions, pressures, cave-ins and flooding); inadequate insurance, or inability to obtain insurance; availability of and costs associated with mining inputs and labour; the speculative nature of mineral exploration and development; diminishing quantities or grades of mineral reserves as properties are mined; risks in obtaining necessary licenses and permits; and challenges to the Company’s title to properties; as well as those factors described in the section “risk factors” contained in the Company’s most recent form 40F/Annual Information Form filed with the S.E.C. and Canadian securities regulatory authorities.

Forward-looking statements are based on assumptions management believes to be reasonable, including but not limited to: the continued operation of the Company’s mining operations, no material adverse change in the market price of commodities, forecasted mine economics, mining operations will operate and the mining products will be completed in accordance with management’s expectations and achieve their stated production outcomes, and such other assumptions and factors as set out herein. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or information, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed or intended. There can be no assurance that any forward-looking statements or information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information.



Triple Flag Announces Election of Directors

Triple Flag Announces Election of Directors

TORONTO–(BUSINESS WIRE)–
Triple Flag Precious Metals Corp. (with its subsidiaries, “Triple Flag” or the “Company”) (TSX: TFPM, NYSE: TFPM) is pleased to announce that each of the nine individuals nominated for election as a director at the Company’s Annual Meeting of Shareholders held on May 6, 2026, was elected.

The detailed voting results are set out below:

Director

Number of Votes

FOR

Percentage of Votes

FOR

Number of Votes

AGAINST

Percentage of Votes

AGAINST

Dawn Whittaker

174,263,323

94.42%

10,301,539

5.58%

Susan Allen

183,905,373

99.64%

659,493

0.36%

Geoff Burns

181,864,740

98.54%

2,700,123

1.46%

Blake Rhodes

183,960,663

99.67%

604,202

0.33%

Mark Cicirelli

184,405,871

99.91%

158,994

0.09%

Christopher McCleave

184,498,099

99.96%

66,766

0.04%

Patrick Merrin

184,503,831

99.97%

61,034

0.03%

Sheldon Vanderkooy

184,486,253

99.96%

78,612

0.04%

Elizabeth Wademan

183,756,497

99.56%

808,368

0.44%

Shareholders also voted in favor of the appointment of PricewaterhouseCoopers LLP as the auditor of the Company and the “Say-on-Pay” advisory resolution regarding the Company’s approach to executive compensation. Each of the resolutions approved at the meeting were described in detail in the Company’s Management Information Circular dated March 24, 2026, available under the Company’s profile on SEDAR+ (www.sedarplus.ca).

A report on all items of business voted at the Annual Meeting of Shareholders has been filed on SEDAR+ (www.sedarplus.ca).

About Triple Flag Precious Metals Corp.

Triple Flag is a precious metals streaming and royalty company. We offer investors exposure to gold and silver from a total of 240 assets, consisting of 16 streams and 224 royalties, primarily from the Americas and Australia. These streams and royalties are tied to mining assets at various stages of the mine life cycle, including 34 producing mines and 206 development and exploration stage projects and other assets. Triple Flag is listed on the Toronto Stock Exchange and New York Stock Exchange under the ticker “TFPM”.

Investor Relations:

David Lee

Vice President, Investor Relations

Tel: +1 (416) 304-9770

Email: [email protected]

Media:

Gordon Poole, Camarco

Tel: +44 (0) 7730 567 938

Email: [email protected]

KEYWORDS: United States North America Canada

INDUSTRY KEYWORDS: Mining/Minerals Natural Resources

MEDIA:

Logo
Logo

Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference

ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A. Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Bank of America 2026 Health Care Conference on Tuesday, May 12, 2026, at 3:40 p.m. PT (6:40 p.m. ET) at the Encore Hotel in Las Vegas, NV.

Investors interested in arranging a meeting with company management during the conference should contact the Bank of America conference coordinator. A live audio webcast of the presentation can be accessed here or by visiting Events & Presentations in the Investor Relations section of the Supernus Pharmaceuticals website at www.supernus.com/Investors. An archived replay of the webcasts will be available for 60 days on the Company’s website following the conference.  

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.

Our diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson’s disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. We are developing a broad range of novel product candidates for CNS disorders.

For more information, please visit www.supernus.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements do not convey historical information but relate to predicted or potential future events that are based upon management’s current expectations. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In addition to the factors mentioned in this press release, such risks and uncertainties include, but are not limited to, the Company’s ability to sustain and increase its profitability; the Company’s ability to raise sufficient capital to fully implement its corporate strategy; the implementation of the Company’s corporate strategy; the Company’s future financial performance and projected expenditures; the Company’s ability to increase the number of prescriptions written for each of its products, and the products of its subsidiaries; the Company’s ability to increase its net revenue from its products, and the products of its subsidiaries; the Company’s ability to commercialize its products, and the products of its subsidiaries; the Company’s ability to enter into future collaborations with pharmaceutical companies and academic institutions or to obtain funding from government agencies; the Company’s product research and development activities, including the timing and progress of the Company’s clinical trials, and projected expenditures; the Company’s ability to receive, and the timing of any receipt of, regulatory approvals to develop and commercialize the Company’s product candidates; the Company’s ability to protect its intellectual property and the intellectual property of its subsidiaries and operate its business without infringing upon the intellectual property rights of others; the Company’s expectations regarding federal, state and foreign regulatory requirements; the therapeutic benefits, effectiveness and safety of the Company’s product candidates; the accuracy of the Company’s estimates of the size and characteristics of the markets that may be addressed by its product candidates; the Company’s ability to increase its manufacturing capabilities for its products and product candidates; the Company’s projected markets and growth in markets; the Company’s product formulations and patient needs and potential funding sources; the Company’s staffing needs; changes to laws and regulations applicable to our industry, the impact of macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs; and other risk factors set forth from time to time in the Company’s filings with the Securities and Exchange Commission made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended. The Company undertakes no obligation to update the information in this press release to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events.

CONTACTS:

Jack A. Khattar, President and CEO
Timothy C. Dec, Senior Vice President and CFO
Supernus Pharmaceuticals, Inc.
(301) 838-2591

or

INVESTOR CONTACT:

Peter Vozzo
ICR Healthcare
(443) 213-0505
[email protected]



Nutrien Reports First Quarter 2026 Results

Nutrien Reports First Quarter 2026 Results

Strong customer demand and solid operational performance in the first quarter

Strategic priorities and capital allocation approach remain unchanged

Full-year guidance ranges reaffirmed

All amounts are in US dollars, except as otherwise noted

SASKATOON, Saskatchewan–(BUSINESS WIRE)–
Nutrien Ltd. (TSX and NYSE: NTR) announced today its first quarter 2026 results, with net earnings of $139 million ($0.27 diluted net earnings per share). First quarter 2026 adjusted EBITDA1 was $1.11 billion and adjusted net earnings per share1 was $0.51.

“Nutrien delivered record potash sales volumes and stronger Nitrogen and Retail performance in the first quarter. We increased production from our low-cost North American assets and positioned our supply chain to reliably supply our customers amid tightening global fertilizer supply and demand fundamentals,” commented Ken Seitz, Nutrien’s President and CEO. “We continue to take purposeful steps to simplify the business, strengthen and grow our core asset base and improve capital efficiency, resulting in a more resilient portfolio and delivering structural free cash flow growth.”

Highlights2:

  • Retail adjusted EBITDA increased to $108 million in the first quarter of 2026 due to higher crop nutrient sales volumes and stronger proprietary products gross margins in the US and Australia. In the first quarter, we completed a tuck-in acquisition of a high-quality retail business located in the US corn belt.

  • Potash adjusted EBITDA increased to $578 million in the first quarter of 2026 due to higher global benchmarks and record sales volumes. We increased potash production and continued to progress mine automation, maintaining our controllable cash cost of product manufactured1 below $60 per tonne.

  • Nitrogen adjusted EBITDA increased to $482 million in the first quarter of 2026 primarily due to higher global benchmarks. Our low-cost North American nitrogen plants delivered an ammonia operating rate3 of 92 percent in the first quarter of 2026, consistent with our planned production and reflective of a continued focus on reliability initiatives.

  • Returned $409 million to shareholders in the first quarter of 2026 through dividends and share repurchases.

  • Progressing as planned with the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business with a focus on enhancing earnings quality and free cash flow.

 

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.
2 Our discussion of highlights set out on this page is a comparison of the results for the three months ended March 31, 2026 to the results for the three months ended March 31, 2025, unless otherwise noted.
3 Excludes Trinidad and Joffre.
 

Management’s Discussion and Analysis

The following management’s discussion and analysis (“MD&A”) is the responsibility of management and is dated as of May 6, 2026. The Board of Directors (“Board”) of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term “Nutrien” refers to Nutrien Ltd. and the terms “we”, “us”, “our”, “Nutrien” and “the Company” refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 19, 2026 (“2025 Annual Report”), which includes our annual audited consolidated financial statements (“annual financial statements”) and MD&A, and our annual information form dated February 19, 2026, each for the year ended December 31, 2025, can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. No update is provided to the disclosure in our 2025 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the “SEC”).

This MD&A is based on, and should be read in conjunction with, the Company’s unaudited interim condensed consolidated financial statements as at and for the three months ended March 31, 2026 (“interim financial statements”) based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard (“IAS”) 34 “Interim Financial Reporting”, unless otherwise noted. This MD&A contains certain non-GAAP financial measures and ratios and forward-looking statements, which are described in the “Non-GAAP Financial Measures” and the “Forward-Looking Statements” sections, respectively.

Market Outlook and Guidance

  • The conflict in the Middle East and related geopolitical uncertainty has disrupted global fertilizer and energy markets, with the most direct impact on nitrogen and phosphate supply from that region, as well as associated feedstock cost and availability. The outlook below reflects current market conditions and ongoing market dynamics.

Agriculture and Retail Markets

  • Higher global grain and oilseed production in 2025 increased stocks-to-use ratios towards historical average levels and led to significant nutrient removal from the soil. Strong demand for food, feed and biofuel is expected to drive continued need for higher global crop production and related crop inputs. Global grain and oilseed prices have strengthened in 2026 due to robust demand and the emergence of regional weather issues that could impact prospective production.

  • We have maintained our US crop acreage projections with corn plantings of 94 to 96 million acres and soybean plantings of 84 to 86 million acres in 2026. We have seen healthy crop input demand over the first four months of 2026 in line with our prior expectations, supported by above average planting progress and the need to replenish soil nutrients following last year’s record crop.

  • In Australia, favorable weather conditions across key cropping regions and strong livestock prices are supporting sales of retail products and services. In Brazil, safrinha corn planting supported crop input demand in the first quarter and growers prioritized potash purchases.

Crop Nutrient Markets

  • Global potash demand remains strong and we have maintained our previous forecast range for global potash shipments of 74 to 77 million tonnes in 2026. We anticipate relatively tight potash fundamentals throughout 2026 with demand trends expected to test existing global operating and supply chain capabilities.

  • Global nitrogen market fundamentals have tightened due to trade flow disruptions and elevated natural gas costs and LNG availability have impacted nitrogen production and costs for producers in Asia, Europe and other key regions. The outlook for the remainder of 2026 is expected to be impacted by uneven restoration of trade flows and restart of nitrogen assets, as well as uncertainty regarding Chinese urea exports and Indian urea imports.

  • Global phosphate supply and demand has been impacted by trade flow disruptions, lower global operating rates due to elevated feedstock costs that have pressured margins, and continued uncertainty regarding Chinese exports.

Financial and Operational Guidance

  • We have maintained all 2026 full year financial and operational guidance ranges.

  • Retail adjusted EBITDA guidance of $1.75 to $1.95 billion represents structural growth in our downstream business consistent with historical rates.

  • Potash sales volume guidance of 14.1 to 14.8 million tonnes is consistent with our global shipment expectation.

  • Nitrogen sales volume guidance of 9.2 to 9.7 million tonnes is supported by planned reliability improvements and debottlenecks.

  • Phosphate sales volume guidance of 2.4 to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.

  • Total capital expenditures guidance of $2.0 to $2.1 billion is consistent with 2025 as we continue to optimize capital to sustain safe and reliable operations and to progress a set of targeted growth investments. The total includes approximately $400 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions and product optimization projects in Nitrogen, and mine automation in Potash.

All guidance numbers, including those noted above, are outlined in the table below. Refer to page 33 of our 2025 Annual Report for anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

 

2026 Guidance Ranges1 as of

 

May 6, 2026

 

February 18, 2026

($ billions, except as otherwise noted)

Low

 

High

 

Low

 

High

Retail adjusted EBITDA

1.75

 

1.95

 

1.75

 

1.95

Potash sales volumes (million tonnes)2

14.1

 

14.8

 

14.1

 

14.8

Nitrogen sales volumes (million tonnes)2

9.2

 

9.7

 

9.2

 

9.7

Phosphate sales volumes (million tonnes)2

2.4

 

2.6

 

2.4

 

2.6

Depreciation and amortization

2.4

 

2.5

 

2.4

 

2.5

Finance costs

0.65

 

0.75

 

0.65

 

0.75

Effective tax rate on adjusted net earnings (%)3

24.0

 

26.0

 

24.0

 

26.0

Capital expenditures4

2.0

 

2.1

 

2.0

 

2.1

1 See the “Forward-Looking Statements” section.

2 Manufactured product only.

3 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the “Other Financial Measures” section.

 

Consolidated Results

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

2025

 

% Change

Sales

6,046

 

5,100

 

19

Gross margin

1,646

 

1,320

 

25

Expenses

1,286

 

1,094

 

18

Net earnings

139

 

19

 

n/m

Adjusted EBITDA1

1,105

 

852

 

30

Diluted net earnings per share (dollars)2

0.27

 

0.02

 

n/m

Adjusted net earnings per share (dollars)1, 2

0.51

 

0.11

 

n/m

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

Net earnings and adjusted EBITDA increased in the first quarter of 2026 primarily due to higher fertilizer global benchmarks, increased Retail earnings and record Potash sales volumes compared to the first quarter of 2025.

Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three months ended March 31, 2026 to the results for the three months ended March 31, 2025, unless otherwise noted.

Retail

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

2025

 

% Change

Sales

3,640

 

3,090

 

18

Cost of goods sold

2,840

 

2,404

 

18

Gross margin

800

 

686

 

17

Adjusted EBITDA1

108

 

46

 

135

1 See Note 2 to the interim financial statements.

  • Retail adjusted EBITDA increased in the first quarter of 2026 due to higher crop nutrient sales volumes and stronger proprietary products gross margins in the US and Australia. Expenses increased due to selling expenses related to higher sales volumes.

 

Three Months Ended

March 31

 

Sales

 

Gross Margin

($ millions)

2026

 

2025

 

2026

 

2025

Crop nutrients

1,483

 

1,194

 

250

 

219

Crop protection products

1,137

 

972

 

226

 

191

Seed

562

 

532

 

84

 

70

Services and other

175

 

146

 

144

 

118

Merchandise

223

 

189

 

36

 

31

Nutrien Financial

80

 

70

 

80

 

70

Nutrien Financial elimination1

(20)

 

(13)

 

(20)

 

(13)

Total

3,640

 

3,090

 

800

 

686

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

  • Crop nutrients sales and gross margin increased in the first quarter of 2026 due to higher sales volumes from our core geographies, including an earlier start to field activity in the US relative to the same period in 2025.
  • Crop protection products sales and gross margin increased in the first quarter of 2026 due to higher sales of proprietary products, supported by earlier field activity in the US relative to the same period in 2025.
  • Seed sales and gross margin increased in the first quarter of 2026 due to higher sales volumes, including higher-margin canola seed.
  • Services and other sales and gross margin increased in the first quarter of 2026 due to a strong livestock market in Australia.

Supplemental Data

Three Months Ended

March 31

 

Gross Margin

 

% of Product Line1

($ millions, except as otherwise noted)

2026

 

2025

 

2026

 

2025

Proprietary products

 

 

 

 

 

 

 

Crop nutrients

80

 

69

 

32

 

31

Crop protection products

88

 

53

 

38

 

28

Seed

21

 

28

 

25

 

40

Merchandise

2

 

3

 

6

 

9

Total

191

 

153

 

24

 

22

1 Represents percentage of proprietary product margins over total product line gross margin.

Three Months Ended

March 31

 

Sales Volumes

(tonnes
thousands)

 

Gross Margin / Tonne

(dollars)

 

2026

 

2025

 

2026

 

2025

Crop nutrients

 

 

 

 

 

 

 

North America

1,600

 

1,464

 

131

 

130

International

848

 

826

 

48

 

34

Total

2,448

 

2,290

 

102

 

95

 

(percentages)

March 31, 2026

 

December 31, 2025

Financial performance measures1, 2

 

 

 

Cash operating coverage ratio

62

 

62

Average working capital to sales

23

 

22

1 Rolling four quarters.

2 These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

Potash

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

2025

% Change

Net sales

926

 

744

 

24

Cost of goods sold

422

 

380

 

11

Gross margin

504

 

364

 

38

Adjusted EBITDA1

578

 

446

 

30

1 See Note 2 to the interim financial statements.

  • Potash adjusted EBITDA increased in the first quarter of 2026 due to higher global benchmarks and record sales volumes. We increased potash production and continued to progress mine automation, maintaining our controllable cash cost of product manufactured1 below $60 per tonne.

Manufactured Product

Three Months Ended

March 31

($ per tonne, except as otherwise noted)

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

North America

1,285

 

1,312

Offshore

2,225

 

2,090

Total sales volumes

3,510

 

3,402

Net selling price

 

 

 

North America

287

 

243

Offshore

250

 

204

Average net selling price

264

 

219

Cost of goods sold

120

 

112

Gross margin

144

 

107

Depreciation and amortization

50

 

46

Gross margin excluding depreciation and amortization1

194

 

153

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

  • Sales volumes in the first quarter of 2026 were the highest on record, supported by low inventory levels and favorable potash affordability in key offshore markets.
  • Net selling priceper tonne increased in the first quarter of 2026 due to higher global benchmark prices.
  • Cost of goods sold per tonne increased in the first quarter of 2026 primarily due to higher depreciation. Controllable cash cost of product manufactured per tonne decreased in the first quarter of 2026 due to higher potash production.

Supplemental Data

Three Months Ended

March 31

 

2026

 

2025

Production volumes (tonnes – thousands)

3,660

 

3,289

Potash controllable cash cost of product manufactured per tonne1

59

 

60

Canpotex sales by market (percentage of sales volumes)2

 

 

 

Latin America

41

 

31

Other Asian markets3

30

 

32

China

17

 

17

India

1

 

4

Other markets

11

 

16

Total

100

 

100

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2 See Note 8 to the interim financial statements.

3 All Asian markets except China and India.

Nitrogen

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

20251, 2

% Change

Net sales

1,014

 

885

 

15

Cost of goods sold

647

 

598

 

8

Gross margin

367

 

287

 

28

Adjusted EBITDA2

482

 

405

 

19

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 See Note 2 to the interim financial statements.

  • Nitrogen adjusted EBITDA increased in the first quarter of 2026 primarily due to higher global benchmarks. Our low-cost North American nitrogen plants delivered an ammonia operating rate2 of 92 percent in the first quarter of 2026, consistent with our planned production and reflective of a continued focus on reliability initiatives.

Manufactured Product

Three Months Ended

March 31

($ per tonne, except as otherwise noted)

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

Ammonia

298

 

496

Urea and ESN®

748

 

795

Solutions, nitrates and sulfates

1,295

 

1,178

Total sales volumes

2,341

 

2,469

Net selling price

 

 

 

Ammonia

479

 

418

Urea and ESN®

515

 

438

Solutions, nitrates and sulfates

282

 

236

Average net selling price

381

 

337

Cost of goods sold

225

 

224

Gross margin

156

 

113

Depreciation and amortization

65

 

58

Gross margin excluding depreciation and amortization1

221

 

171

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

  • Sales volumes decreased in the first quarter of 2026, reflecting no production from the Trinidad and New Madrid facilities4, partially offset by higher solutions, nitrates and sulfates sales volumes supported by reliability and debottleneck initiatives.
  • Net selling price per tonne was higher in the first quarter of 2026 for all major nitrogen products due to stronger global benchmark prices.
  • Cost of goods sold per tonne was flat in the first quarter of 2026, as lower overall natural gas costs were offset by higher depreciation and other variable costs. The lower overall natural gas cost reflects a higher proportion of production from our low-cost North American nitrogen plants compared to the same period of 2025.

Supplemental Data

Three Months Ended

March 31

 

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

Fertilizer

1,409

 

1,389

Industrial and feed

932

 

1,080

Production volumes (tonnes – thousands)

 

 

 

Ammonia production – total1

1,122

 

1,543

Ammonia production – adjusted1, 2

1,019

 

1,076

Ammonia operating rate (%)2

92

 

98

Natural gas costs (dollars per MMBtu)

 

 

 

Overall natural gas cost excluding realized derivative impact

3.28

 

3.91

Realized derivative impact3

 

Overall natural gas cost

3.28

 

3.91

1 All figures are provided on a gross production basis in thousands of product tonnes.

2 Excludes Trinidad and Joffre.

3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses.

4 As previously disclosed, on October 23, 2025, the Trinidad nitrogen facility completed a controlled shutdown and we ceased production at our New Madrid nitrogen upgrade facility at year-end 2025.

Phosphate

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

2025

% Change

Net sales

485

 

360

 

35

Cost of goods sold

489

 

361

 

35

Gross margin

(4)

 

(1)

 

n/m

Adjusted EBITDA1

57

 

61

 

(7)

1 See Note 2 to the interim financial statements.

  • Phosphate adjusted EBITDA decreased in the first quarter of 2026 due to higher sulfur input costs, partially offset by higher global benchmarks and sales volumes compared to the same period of 2025.

Manufactured Product

Three Months Ended

March 31

($ per tonne, except as otherwise noted)

2026

 

2025

Sales volumes (tonnes – thousands)

 

 

 

Fertilizer

468

 

332

Industrial and feed

190

 

168

Total sales volumes

658

 

500

Net selling price

 

 

 

Fertilizer

668

 

656

Industrial and feed

883

 

817

Average net selling price

730

 

710

Cost of goods sold

726

 

700

Gross margin

4

 

10

Depreciation and amortization

109

 

144

Gross margin excluding depreciation and amortization1

113

 

154

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

  • Sales volumes were higher in the first quarter of 2026 due to higher production volumes from reliability improvements compared to the same period of 2025.
  • Net selling price per tonne increased in the first quarter of 2026 due to stronger global benchmark prices.
  • Cost of goods sold per tonne increased in the first quarter of 2026 primarily due to higher sulfur input costs, more than offsetting higher production volumes that improved cost absorption and lowered depreciation per tonne compared to the same period of 2025.

Supplemental Data

Three Months Ended

March 31

 

2026

 

2025

Production volumes (P2O5 tonnes – thousands)

337

 

282

P2O5 operating rate (%)

80

67

 

Corporate and Others and Eliminations

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

20251, 2

 

% Change

Corporate and Others

 

 

 

 

 

Gross margin2

14

 

14

 

Selling recovery

(3)

 

(3)

 

General and administrative expenses

111

 

99

 

12

Share-based compensation expense

116

 

42

 

176

Foreign exchange loss, net of related derivatives

5

 

7

 

(29)

Other expenses

10

 

18

 

(44)

Adjusted EBITDA2

(84)

 

(78)

 

8

Eliminations

 

 

 

 

 

Gross margin

(35)

 

(30)

 

17

Adjusted EBITDA2

(36)

 

(28)

 

29

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 See Note 2 to the interim financial statements.
  • Share-based compensation expense was higher in the first quarter of 2026 due to an increase in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors, such as our share price movement, our performance relative to our peer group and our return on invested capital.

Finance Costs, Income Taxes and Other Comprehensive (Loss) Income

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

2025

 

% Change

Finance costs

176

 

179

 

(2)

Income taxes

 

 

 

 

 

Income tax expense

45

 

28

 

61

Actual effective tax rate including discrete items (%)

24

 

60

 

(60)

Other comprehensive income

66

 

25

 

164

  • Income tax expense increased in the first quarter of 2026 mainly due to higher earnings. The actual effective tax rate including discrete items decreased due to a change in the proportion of earnings (loss) between tax jurisdictions.

Liquidity and Capital Resources

Sources and uses of liquidity

We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the “Capital Structure and Management” section for details on our existing long-term debt and credit facilities.

Sources and uses of cash

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

2025

 

% Change

Cash used in operating activities

(851)

 

(1,082)

 

(21)

Cash used in investing activities

(487)

 

(243)

 

100

Cash provided by financing activities

1,426

 

1,365

 

4

Cash used for dividends and share repurchases1

(409)

 

(413)

 

(1)

1 This is a supplementary financial measure. See the “Other Financial Measures” section.

 

Cash used in operating activities

  • Cash used in operating activities in the first quarter of 2026 was lower compared to the same period in 2025 primarily due to higher fertilizer global benchmarks, increased Retail earnings and record Potash sales volumes.

Cash used in investing activities

  • Cash used in investing activities in the first quarter of 2026 was higher compared to the same period in 2025 due to higher cash used on business acquisitions in 2026. The 2025 comparative period included proceeds from the disposal of our investment in Sinofert Holdings Limited.

Cash provided by financing activities

  • Cash provided by financing activities in the first quarter of 2026 was higher compared to the same period in 2025 due to higher commercial paper issuances in 2026. Additionally, in 2025, we issued $1.0 billion of senior notes. We had no issuances of senior notes in the first quarter of 2026.

Cash used for dividends and share repurchases

  • Cash used for dividends and share repurchases was consistent in the first quarter of 2026 compared to the same period in 2025.

 
 

Financial Condition Review

The following is a comparison of balance sheet categories that are considered material:

 

As at

 

 

 

 

($ millions, except as otherwise noted)

March 31, 2026

 

December 31, 2025

 

$ Change

 

% Change

Assets

 

 

 

 

 

 

 

Cash and cash equivalents

777

 

701

 

76

 

11

Receivables

6,284

 

5,675

 

609

 

11

Inventories

8,681

 

6,977

 

1,704

 

24

Prepaid expenses and other current assets

733

 

1,396

 

(663)

 

(47)

Property, plant and equipment

22,659

 

22,747

 

(88)

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

 

Short-term debt

2,766

 

873

 

1,893

 

217

Trade, other payables and accrued liabilities

9,137

 

9,309

 

(172)

 

(2)

Long-term debt, including current portion

9,861

 

9,863

 

(2)

 

Share capital

13,515

 

13,519

 

(4)

 

Retained earnings

11,853

 

12,076

 

(223)

 

(2)

  • Explanations for changes in Cash and cash equivalents are in the “Liquidity and Capital Resources – Sources and uses of cash” section.

  • Receivables increased due to higher fertilizer global benchmarks and the seasonality of our Retail segment, resulting in higher receivables with customers and vendor rebates, partially offset by improved collection of receivables in North America. Receivables also increased from record Potash sales volumes.
  • Inventories increased due to the seasonality of our Retail segment. Our North American inventory levels generally increase at year-end, peak in the first quarter of the year in preparation for the planting and application seasons, and are drawn down in the succeeding quarters.
  • Prepaid expenses and other current assets decreased due to Retail taking delivery of prepaid inventories in preparation for the spring planting and applications season in North America.
  • Short-term debt increased due to higher commercial paper issuances to support working capital requirements driven by the seasonality of our business.
  • Trade, other payables and accrued liabilities decreased due to the settlement in the first quarter of 2026 of our Retail supplier financing arrangement obligations that were entered into in the fourth quarter of 2025. This was partially offset by higher Retail customer prepayments received in the first quarter of 2026 in anticipation of crop input price increases.

Capital Structure and Management

Principal debt instruments

As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We continually evaluate various financing arrangements and may seek to engage in transactions from time to time when market and other conditions are favorable. We were in compliance with our debt covenants and did not have any changes to our credit ratings for the three months ended March 31, 2026.

Capital structure (debt and equity)

($ millions)

March 31, 2026

 

December 31, 2025

Short-term debt

2,766

 

873

Current portion of long-term debt

1,036

 

513

Current portion of lease liabilities

362

 

346

Long-term debt

8,825

 

9,350

Lease liabilities

957

 

937

Shareholders’ equity

25,192

 

25,365

 

Commercial paper, credit facilities and other debt

We have a total facility limit of approximately $7,426 million comprised of several credit facilities available in the jurisdictions where we operate. In North America, we have a commercial paper program, which is limited to the undrawn amount under our $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

As at March 31, 2026, we utilized $2,780 million of our total facility limit, which includes $2,421 million of commercial paper outstanding. In the first quarter of 2026, we extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028 and entered into a $69 million uncommitted revolving demand facility.

As at March 31, 2026, $234 million in letters of credit were outstanding and committed, with $352 million of remaining credit available under our letter of credit facilities.

Our long-term debt consists primarily of notes and debentures. See the “Capital Structure and Management” section of our 2025 Annual Report for information on balances, rates and maturities for our notes and debentures.

Outstanding share data

 

As at May 5, 2026

Common shares

480,023,548

Options to purchase common shares

1,921,277

For more information on our capital management, see Note 4 to the annual financial statements in our 2025 Annual Report.

Quarterly Results

($ millions, except as otherwise noted)

Q1 2026

Q4 2025

Q3 2025

Q2 2025

Q1 2025

Q4 2024

Q3 2024

Q2 2024

Sales

6,046

 

5,340

 

6,007

 

10,438

 

5,100

 

5,079

 

5,348

 

10,156

Net earnings

139

 

580

 

469

 

1,229

 

19

 

118

 

25

 

392

Net earnings attributable to equity holders of Nutrien

131

 

571

 

464

 

1,221

 

11

 

113

 

18

 

385

Net earnings per share attributable to equity holders of Nutrien

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

0.27

 

1.18

 

0.96

 

2.51

 

0.02

 

0.23

 

0.04

 

0.78

Diluted

0.27

 

1.18

 

0.96

 

2.50

 

0.02

 

0.23

 

0.04

 

0.78

Our quarterly earnings are significantly affected by the seasonality of our business, fertilizer benchmark prices, global demand-supply conditions, grower affordability and weather. See Note 2 to the interim financial statements.

Accounting Policies and New IFRS Standards

Significant accounting policies are disclosed in our 2025 Annual Report and have been consistently applied for the three months ended March 31, 2026, except as described below.

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The impact was not material. On initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the three months ended March 31, 2026.

Critical Accounting Estimates

The preparation of financial statements in accordance with IFRS requires management to make estimates and judgments that affect reported assets, liabilities, revenues and expenses. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board.

Our critical accounting estimates are discussed on pages 64 to 65 of our 2025 Annual Report. There were no material changes to our critical accounting estimates for the three months ended March 31, 2026.

Controls and Procedures

Management is responsible for establishing and maintaining adequate internal control over financial reporting (“ICFR”), as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings. ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of ICFR, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

There has been no change in our ICFR during the three months ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, our ICFR.

Forward-Looking Statements

Certain statements and other information included in this document, including within the “Market Outlook and Guidance” section, constitute “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) under applicable securities laws (such statements are often accompanied by words such as “anticipate”, “forecast”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “project”, “intend” or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien’s business strategies, plans, prospects and opportunities; Nutrien’s 2026 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business and associated outcomes; expectations regarding structural growth in our downstream business; expectations regarding our capital allocation approach and strategies, including our intentions with respect to our strategic actions and the expected timing thereof; our expectations regarding Nutrien’s strategic priorities and our ability to advance and achieve such strategic priorities in 2026 and beyond; expectations regarding various performance targets in 2026 and beyond and our ability to achieve such targets; capital spending expectations for 2026 and beyond; expectations regarding performance of our operating segments in 2026 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, crop input demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix and the need to replenish soil nutrient levels, input costs, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates, the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, geopolitical disruptions, including the ongoing conflict in the Middle East, inventories, crop development, and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to generate free cash flow, enhance earnings quality, and deliver long-term returns to shareholders.

These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives; that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes and gross margins; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and realize the expected synergies on the anticipated timeline or at all; increased proprietary products gross margin; successful execution of the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, within the anticipated timing and parameters, and realization of the expected benefits therefrom; continued reliability improvements; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, operating rates, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, government support, crop development and cost of labor and interest, exchange and effective tax rates; global economic conditions and the accuracy of our market outlook expectations for 2026 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the ongoing conflict in the Middle East, on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; the availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets; failure to complete announced and future strategic and asset optimization initiatives, acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality of our business; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements) and regulatory investigations; current and future litigation proceedings; the results of our review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, including the process and the timing thereof, and whether the review will result in Nutrien undertaking a transaction, including the terms and timing relating thereto, the completion thereof and the benefits to be realized therefrom; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions; government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts, including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the ongoing conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the “Terms and definitions” section of our 2025 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, “n/m” indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.

About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve farmers. Our vision is to be the leading global agricultural solutions provider, delivering superior shareholder value through safe and sustainable operations. To achieve this vision, our strategy is anchored in three priorities: simplify and focus, operational excellence and a disciplined and intentional approach to capital allocation. This strategy is designed to create low-risk, structural free cash flow growth by leveraging our core competencies and to deliver reliable, growing cash returns to shareholders.

More information about Nutrien can be found at www.nutrien.com.

Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

Such data is not incorporated by reference herein.

Nutrien will host a Conference Call on Thursday, May 7, 2026 at 10:00 a.m. Eastern Time.

Telephone conference dial-in numbers:

  • From Canada and the US: 1-800-990-2777

  • International: 1-416-855-9085

  • Conference ID: 89180. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

Live Audio Webcast: Visit https://www.nutrien.com/news/events/2026-q1-earnings-conference-call

Non-GAAP Financial Measures

We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, asset retirement obligations (“ARO”) and accrued environmental costs (“ERL”) related to our non-operating sites, and loss related to financial instruments in Argentina.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

 

Three Months Ended

March 31

($ millions)

2026

 

2025

Net earnings

139

 

19

Finance costs

176

 

179

Income tax expense

45

 

28

Depreciation and amortization

606

 

571

EBITDA1

966

 

797

Adjustments:

 

 

 

Share-based compensation expense

116

 

42

Foreign exchange loss, net of related derivatives

5

 

7

ARO/ERL related (income) expenses for non-operating sites

(28)

 

5

Restructuring costs

16

 

1

Impairment of assets recorded in other income and expenses

30

 

Adjusted EBITDA

1,105

 

852

1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

 

Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

 

Three Months Ended

March 31, 2026

 

 

 

 

 

Per

 

Increases

 

 

 

Diluted

($ millions, except as otherwise noted)

(Decreases)

 

Post-Tax

 

Share

Net earnings attributable to equity holders of Nutrien

 

 

131

 

0.27

Adjustments:

 

 

 

 

 

Share-based compensation expense

116

 

88

 

0.18

Foreign exchange loss, net of related derivatives

5

 

10

 

0.02

Restructuring costs

16

 

16

 

0.03

Impairment of assets recorded in other income and expenses

30

 

22

 

0.05

ARO/ERL related (income) for non-operating sites

(28)

 

(22)

 

(0.04)

Sub-total adjustments

139

 

114

 

0.24

Adjusted net earnings

 

 

245

 

0.51

 

 

Three Months Ended

March 31, 2025

 

 

 

 

 

Per

 

Increases

 

 

 

Diluted

($ millions, except as otherwise noted)

(Decreases)

 

Post-Tax

 

Share

Net earnings attributable to equity holders of Nutrien

 

 

11

 

0.02

Adjustments:

 

 

 

 

 

Share-based compensation expense

42

 

31

 

0.06

Foreign exchange loss, net of related derivatives

7

 

6

 

0.01

Restructuring costs

1

 

1

 

ARO/ERL related expenses for non-operating sites

5

 

4

 

0.02

Sub-total adjustments

55

 

42

 

0.09

Adjusted net earnings

 

 

53

 

0.11

 

Effective Tax Rate on Adjusted Net Earnings

Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the “Segment Results” section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Controllable Cash Cost of Product Manufactured (“COPM”) Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold (“COGS”) for the Potash segment.

Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

 

Three Months Ended

March 31

($ millions, except as otherwise noted)

2026

 

2025

Total COGS – Potash

422

 

380

Change in inventory

8

 

7

Other adjustments1

(5)

 

(13)

COPM

425

 

374

Depreciation and amortization in COPM

(171)

 

(145)

Royalties in COPM

(26)

 

(19)

Natural gas costs and carbon taxes in COPM

(13)

 

(12)

Controllable cash COPM

215

 

198

Production volumes (tonnes – thousands)

3,660

 

3,289

Potash controllable cash COPM per tonne

59

 

60

1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

Retail Cash Operating Coverage Ratio

Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

 

Rolling Four Quarters Ended March 31, 2026

($ millions, except as otherwise noted)

Q2 2025

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

Total

Selling expenses

948

 

792

 

811

 

798

 

3,349

General and administrative expenses

44

 

44

 

40

 

44

 

172

Other expenses

54

 

40

 

4

 

36

 

134

Operating expenses

1,046

 

876

 

855

 

878

 

3,655

Depreciation and amortization in operating expenses

(172)

 

(179)

 

(184)

 

(179)

 

(714)

Operating expenses excluding depreciation and amortization

874

 

697

 

671

 

699

 

2,941

 

 

 

 

 

 

 

 

 

 

Gross margin

2,018

 

922

 

977

 

800

 

4,717

Depreciation and amortization in cost of goods sold

5

 

5

 

5

 

5

 

20

Gross margin excluding depreciation and amortization

2,023

 

927

 

982

 

805

 

4,737

Cash operating coverage ratio (%)

 

 

 

 

 

 

 

 

62

 

 

 

 

 

 

 

 

 

 

 

Rolling Four Quarters Ended December 31, 2025

($ millions, except as otherwise noted)

Q1 2025

 

Q2 2025

 

Q3 2025

 

Q4 2025

 

Total

Selling expenses

755

 

948

 

792

 

811

 

3,306

General and administrative expenses

44

 

44

 

44

 

40

 

172

Other expenses

25

 

54

 

40

 

4

 

123

Operating expenses

824

 

1,046

 

876

 

855

 

3,601

Depreciation and amortization in operating expenses

(179)

 

(172)

 

(179)

 

(184)

 

(714)

Operating expenses excluding depreciation and amortization

645

 

874

 

697

 

671

 

2,887

 

 

 

 

 

 

 

 

 

 

Gross margin

686

 

2,018

 

922

 

977

 

4,603

Depreciation and amortization in cost of goods sold

5

 

5

 

5

 

5

 

20

Gross margin excluding depreciation and amortization

691

 

2,023

 

927

 

982

 

4,623

Cash operating coverage ratio (%)

 

 

 

 

 

 

 

 

62

 

Retail Average Working Capital to Sales

Definition: Retail average working capital divided by Retail sales for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively.

 

Rolling Four Quarters Ended March 31, 2026

($ millions, except as otherwise noted)

Q2 2025

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

 

Average/Total

Current assets

11,442

 

10,823

 

11,185

 

12,558

 

 

 

Current liabilities

(8,051)

 

(5,348)

 

(8,275)

 

(7,799)

 

 

 

Working capital

3,391

 

5,475

 

2,910

 

4,759

 

 

4,134

 

 

 

 

 

 

 

 

 

 

 

Sales

7,959

 

3,427

 

3,144

 

3,640

 

 

18,170

Average working capital to sales (%)

 

 

 

 

 

 

 

 

 

23

 

 

 

 

 

 

 

 

 

 

 

 

Rolling Four Quarters Ended December 31, 2025

($ millions, except as otherwise noted)

Q1 2025

 

Q2 2025

 

Q3 2025

 

Q4 2025

 

 

Average/Total

Current assets

11,510

 

11,442

 

10,823

 

11,185

 

 

 

Current liabilities

(7,561)

 

(8,051)

 

(5,348)

 

(8,275)

 

 

 

Working capital

3,949

 

3,391

 

5,475

 

2,910

 

 

3,931

 

 

 

 

 

 

 

 

 

 

 

Sales

3,090

 

7,959

 

3,427

 

3,144

 

 

17,620

Average working capital to sales (%)

 

 

 

 

 

 

 

 

 

22

   
   

Other Financial Measures

Selected Additional Financial Data

Nutrien Financial Aging

As at March 31, 2026

As at

December 31, 2025

($ millions)

Current

<31 Days

past due

31–90 Days

past due

>90 Days

past due

Gross receivables

Allowance1

 

Net receivables2

Net

receivables

North America

1,566

89

223

196

2,074

(55)

 

2,019

2,332

International

879

64

53

26

1,022

(6)

 

1,016

774

Nutrien Financial

receivables

2,445

153

276

222

3,096

(61)

 

3,035

3,106

1 Bad debt expense on the above receivables for the three months ended March 31, 2026 was $9 million, in the Retail segment.

2 In 2026, we assume a debt-to-equity ratio of 9:1 (2025 – 9:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

   

Nutrien Financial Net Receivables

Rolling Four Quarters Ended March 31, 2026

($ millions, except as otherwise noted)

Q2 2025

 

Q3 2025

 

Q4 2025

 

Q1 2026

 

 

Average/Total

Average Nutrien Financial net receivables

4,645

 

4,452

 

3,106

 

3,035

 

 

3,810

   

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien’s shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of cash to shareholders.

Condensed Consolidated Financial Statements

Unaudited

Condensed Consolidated Statements of Earnings

 

 

Three Months Ended

 

 

March 31

($ millions, except as otherwise noted)

Note

2026

 

2025

Sales

2, 8

6,046

 

5,100

Freight, transportation and distribution

 

244

 

226

Cost of goods sold

 

4,156

 

3,554

Gross Margin

 

1,646

 

1,320

Selling expenses

 

799

 

757

General and administrative expenses

 

164

 

152

Provincial mining taxes

 

90

 

68

Share-based compensation expense

 

116

 

42

Foreign exchange loss, net of related derivatives

 

3

 

7

Other expenses

3

114

 

68

Earnings Before Finance Costs and Income Taxes

360

 

226

Finance costs

 

176

 

179

Earnings Before Income Taxes

 

184

 

47

Income tax expense

4

45

 

28

Net Earnings

 

139

 

19

Attributable to

 

 

 

 

Equity holders of Nutrien

 

131

 

11

Non-controlling interest

 

8

 

8

Net Earnings

 

139

 

19

 

 

 

 

 

Net Earnings Per Share Attributable to Equity Holders of Nutrien (“EPS”)

Basic

 

0.27

 

0.02

Diluted

 

0.27

 

0.02

Weighted average shares outstanding for basic EPS

 

481,260,000

 

489,397,000

Weighted average shares outstanding for diluted EPS

 

481,647,000

 

489,540,000

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Comprehensive Income

 

Three Months Ended

 

March 31

($ millions, net of related income taxes)

2026

 

2025

Net Earnings

139

 

19

Other comprehensive income

 

 

 

Items that will not be reclassified to net earnings:

 

 

 

Net fair value loss on investments

 

(18)

Items that have been or may be subsequently reclassified to net earnings:

 

 

 

Gain on currency translation of foreign operations

72

 

39

Other

(6)

 

4

Other Comprehensive Income

66

 

25

Comprehensive Income

205

 

44

Attributable to

 

 

 

Equity holders of Nutrien

196

 

36

Non-controlling interest

9

 

8

Comprehensive Income

205

 

44

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Cash Flows

 

 

Three Months Ended

 

 

March 31

($ millions)

Note

2026

 

2025

Operating Activities

 

 

 

 

Net earnings

 

139

 

19

Adjustments for:

 

 

 

 

Depreciation and amortization

 

606

 

571

Share-based compensation expense

 

116

 

42

Provision for deferred income tax

 

41

 

80

Net undistributed earnings of equity-accounted investees

 

(1)

 

(5)

Long-term income tax receivables and payables

 

(15)

 

(38)

Other long-term assets, liabilities and miscellaneous

 

27

 

5

Cash from operations before working capital changes

 

913

 

674

Changes in non-cash operating working capital:

 

 

 

 

Receivables

 

(530)

 

(143)

Inventories and prepaid expenses and other current assets

 

(991)

 

(1,274)

Trade, other payables and accrued liabilities

 

(243)

 

(339)

Cash Used in Operating Activities

 

(851)

 

(1,082)

Investing Activities

 

 

 

 

Capital expenditures1

 

(325)

 

(300)

Business acquisitions, net of cash acquired

 

(50)

 

(11)

Purchase of investments, held within three months, net

 

(8)

 

(16)

Purchase of investments

 

 

(2)

Proceeds from sale of investments

 

 

183

Net changes in non-cash working capital

 

(94)

 

(88)

Other

 

(10)

 

(9)

Cash Used in Investing Activities

 

(487)

 

(243)

Financing Activities

 

 

 

 

Proceeds from debt, maturing within three months, net

 

1,921

 

912

Proceeds from debt

 

998

Repayment of debt

(9)

 

(4)

Repayment of principal portion of lease liabilities

 

(100)

 

(110)

Dividends paid to Nutrien’s shareholders

7

(262)

 

(265)

Repurchase of common shares

7

(147)

 

(148)

Issuance of common shares

 

45

 

3

Other

 

(22)

 

(21)

Cash Provided by Financing Activities

 

1,426

 

1,365

Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

1

 

2

Increase in Cash and Cash Equivalents

 

89

 

42

January 1, 2026 opening balance prior to restatement for amendments to IFRS 9

9

701

 

Adjustment on initial application of amendments to IFRS 9 on January 1, 2026

9

(13)

 

Cash and Cash Equivalents – Beginning of Period

 

688

 

853

Cash and Cash Equivalents – End of Period

 

777

 

895

Cash and cash equivalents is composed of:

 

 

 

 

Cash

 

712

 

828

Short-term investments

 

65

 

67

 

 

777

 

895

Supplemental Cash Flows Information

 

 

 

 

Interest paid

 

148

 

132

Income taxes paid

 

37

 

7

Total cash outflow for leases

 

137

 

150

1 Includes additions to property, plant and equipment, and intangible assets for the three months ended March 31, 2026 of $299 million and $26 million (2025 – $279 million and $21 million).

 

(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

 

 

 

 

 

 

Accumulated other comprehensive

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(loss) income (“AOCI”)

 

 

 

 

 

 

 

($ millions, inclusive of related tax, except as otherwise noted)

Number of

common

shares

 

Share

capital

 

Contributed

surplus

 

(Loss) gain

on currency

translation

of foreign

operations

 

Other

 

Total

AOCI

 

Retained

earnings

 

Equity

holders

of

Nutrien

 

Non-

controlling

interest

 

Total

equity

Balance – December 31, 2024

491,025,446

 

13,748

 

68

 

(537)

 

22

 

(515)

 

11,106

 

24,407

 

35

 

24,442

Net earnings

 

 

 

 

 

 

11

 

11

 

8

 

19

Other comprehensive income (loss)

 

 

 

39

 

(14)

 

25

 

 

25

 

 

25

Shares repurchased for cancellation (Note 7)

(2,862,814)

 

(80)

 

 

 

 

 

(69)

 

(149)

 

 

(149)

Dividends declared1

 

 

 

 

 

 

(266)

 

(266)

 

 

(266)

Non-controlling interest transactions

 

 

 

 

 

 

 

 

(11)

 

(11)

Effect of share-based compensation including issuance of common shares

59,751

 

3

 

1

 

 

 

 

 

4

 

 

4

Transfer of net gain on sale of investment

 

 

 

 

(27)

 

(27)

 

27

 

 

 

Transfer of net loss on cash flow hedges

 

 

 

 

6

 

6

 

 

6

 

 

6

Balance – March 31, 2025

488,222,383

 

13,671

 

69

 

(498)

 

(13)

 

(511)

 

10,809

 

24,038

 

32

 

24,070

Balance – December 31, 2025

481,962,233

 

13,519

 

57

 

(329)

 

 

(329)

 

12,076

 

25,323

 

42

 

25,365

Net earnings

 

 

 

 

 

 

131

 

131

 

8

 

139

Other comprehensive income (loss)

 

 

 

71

 

(6)

 

65

 

 

65

 

1

 

66

Shares repurchased for cancellation (Note 7)

(2,081,503)

 

(58)

 

 

 

 

 

(90)

 

(148)

 

 

(148)

Dividends declared1

 

 

 

 

 

 

(264)

 

(264)

 

 

(264)

Non-controlling interest transactions

 

 

 

 

 

 

 

 

(13)

 

(13)

Effect of share-based compensation including issuance of common shares

876,975

 

54

 

(8)

 

 

 

 

 

46

 

 

46

Transfer of net loss on cash flow hedges

 

 

 

 

1

 

1

 

 

1

 

 

1

Balance – March 31, 2026

480,757,705

 

13,515

 

49

 

(258)

 

(5)

 

(263)

 

11,853

 

25,154

 

38

 

25,192

1 During the three months ended March 31, 2026, we declared dividends of $0.55 per share (2025 – $0.545 per share).

 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

Condensed Consolidated Balance Sheets

 

 

 

 

As at

 

 

As at March 31

 

December 31

($ millions)

Note

2026

 

2025

 

2025

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

777

 

895

 

701

Receivables

8

6,284

 

5,612

 

5,675

Inventories

 

8,681

 

7,992

 

6,977

Prepaid expenses and other current assets

 

733

 

863

 

1,396

 

 

16,475

 

15,362

 

14,749

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

 

22,659

 

22,488

 

22,747

Goodwill

 

12,176

 

12,058

 

12,136

Intangible assets

 

1,621

 

1,791

 

1,667

Investments

 

146

 

495

 

144

Other assets

 

846

 

875

 

858

Total Assets

 

53,923

 

53,069

 

52,301

Liabilities

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Short-term debt

6

2,766

 

2,437

 

873

Current portion of long-term debt

 

1,036

 

1,038

 

513

Current portion of lease liabilities

 

362

 

364

 

346

Trade, other payables and accrued liabilities

8

9,137

 

8,752

 

9,309

 

 

13,301

 

12,591

 

11,041

Non-current liabilities

 

 

 

 

 

 

Long-term debt

 

8,825

 

9,870

 

9,350

Lease liabilities

 

957

 

998

 

937

Deferred income tax liabilities

 

3,701

 

3,591

 

3,666

Pension and other post-retirement benefit liabilities

 

218

 

225

 

221

Asset retirement obligations and accrued environmental costs

 

1,478

 

1,528

 

1,468

Other non-current liabilities

 

251

 

196

 

253

Total Liabilities

 

28,731

 

28,999

 

26,936

Shareholders’ Equity

 

 

 

 

 

 

Share capital

7

13,515

 

13,671

 

13,519

Contributed surplus

 

49

 

69

 

57

Accumulated other comprehensive loss

 

(263)

 

(511)

 

(329)

Retained earnings

 

11,853

 

10,809

 

12,076

Equity holders of Nutrien

 

25,154

 

24,038

 

25,323

Non-controlling interest

 

38

 

32

 

42

Total Shareholders’ Equity

 

25,192

 

24,070

 

25,365

Total Liabilities and Shareholders’ Equity

 

53,923

 

53,069

 

52,301

 

 

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three Months Ended March 31, 2026

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2025 annual audited consolidated financial statements with the exception of the amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, which were adopted effective January 1, 2026 (refer to Note 9). These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2025 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

Certain immaterial 2025 figures have been reclassified in Note 2 Segment information.

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on May 6, 2026.

Note 2 Segment information

We have four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, Australia and South America. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core businesses. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

In the fourth quarter of 2025, the Chief Operating Decision Maker (“CODM”) reassessed our product groupings and determined that the performance of our Purchase for Resale business should be evaluated as part of the Corporate and Others segment. It had previously been presented in our Nitrogen segment. The Purchase for Resale business focuses primarily on sales to international customers. Purchased product that remains in upstream is primarily purchases of inventory to satisfy sales contracts that we cannot fulfill with our manufactured products. The CODM concluded this change was appropriate based on the nature and strategic alignment of purchase for resale activities. Comparative amounts for the Corporate and Others and Nitrogen segments were reclassified. As a result of the reclassification, the Corporate and Others segment reflected the following increases and the Nitrogen segment reflected the corresponding decreases for the three months ended March 31, 2025.

 

 

Three Months Ended

($ millions)

 

March 31, 2025

Sales

 

70

Gross Margin

 

4

EBITDA

 

3

 

 

Three Months Ended March 31, 2026

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

 

Nitrogen

 

Phosphate

 

and Others

 

Eliminations

 

Consolidated

Sales

– third party

3,640

 

966

 

884

 

478

 

78

 

 

6,046

 

– intersegment

 

75

 

247

 

69

 

 

(391)

 

Sales

– total

3,640

 

1,041

 

1,131

 

547

 

78

 

(391)

 

6,046

Freight, transportation and distribution1

 

115

 

117

 

62

 

 

(50)

 

244

Net sales

3,640

 

926

 

1,014

 

485

 

78

 

(341)

 

5,802

Cost of goods sold

2,840

 

422

 

647

 

489

 

64

 

(306)

 

4,156

Gross margin

800

 

504

 

367

 

(4)

 

14

 

(35)

 

1,646

Selling expenses (recovery)

798

 

3

 

6

 

2

 

(3)

 

(7)

 

799

General and administrative expenses

44

 

3

 

4

 

2

 

111

 

 

164

Provincial mining taxes

 

90

 

 

 

 

 

90

Share-based compensation expense

 

 

 

 

116

 

 

116

Foreign exchange (gain) loss, net of related derivatives

(2)

 

 

 

 

5

 

 

3

Other expenses

36

 

26

 

27

 

7

 

10

 

8

 

114

Earnings (loss) before finance costs and income taxes

(76)

 

382

 

330

 

(15)

 

(225)

 

(36)

 

360

Depreciation and amortization

184

 

175

 

152

 

72

 

23

 

 

606

EBITDA

108

 

557

 

482

 

57

 

(202)

 

(36)

 

966

Restructuring costs (Note 3)

 

 

 

 

16

 

 

16

Share-based compensation expense

 

 

 

 

116

 

 

116

Impairment of assets recorded in other income and expenses (Note 3)

 

21

 

 

 

9

 

 

30

ARO/ERL related income for non-operating sites2 (Note 3)

 

 

 

 

(28)

 

 

(28)

Foreign exchange loss, net of related derivatives

 

 

 

 

5

 

 

5

Adjusted EBITDA

108

 

578

 

482

 

57

 

(84)

 

(36)

 

1,105

1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

 

 

Three Months Ended March 31, 2025

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

Nitrogen1

 

Phosphate

 

and Others1

 

Eliminations

 

Consolidated

Sales

– third party

3,090

 

766

822

 

338

 

84

 

 

5,100

 

– intersegment

 

95

182

 

67

 

 

(344)

 

Sales

– total

3,090

 

861

1,004

 

405

 

84

 

(344)

 

5,100

Freight, transportation and distribution2

 

117

119

 

45

 

1

 

(56)

 

226

Net sales

3,090

 

744

885

 

360

 

83

 

(288)

 

4,874

Cost of goods sold

2,404

 

380

598

 

361

 

69

 

(258)

 

3,554

Gross margin

686

 

364

287

 

(1)

 

14

 

(30)

 

1,320

Selling expenses (recovery)

755

 

3

7

 

2

 

(3)

 

(7)

 

757

General and administrative expenses

44

 

2

5

 

2

 

99

 

 

152

Provincial mining taxes

 

68

 

 

 

 

68

Share-based compensation expense

 

 

 

42

 

 

42

Foreign exchange loss, net of related derivatives

 

 

 

7

 

 

7

Other expenses

25

 

2

12

 

6

 

18

 

5

 

68

Earnings (loss) before finance costs and income taxes

(138)

 

289

263

 

(11)

 

(149)

 

(28)

 

226

Depreciation and amortization

184

 

157

142

 

72

 

16

 

 

571

EBITDA

46

 

446

405

 

61

 

(133)

 

(28)

 

797

Restructuring costs (Note 3)

 

 

 

1

 

 

1

Share-based compensation expense

 

 

 

42

 

 

42

ARO/ERL related expenses for non-operating sites (Note 3)

 

 

 

5

 

 

5

Foreign exchange loss, net of related derivatives

 

 

 

7

 

 

7

Adjusted EBITDA

46

 

446

405

 

61

 

(78)

 

(28)

 

852

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

Three Months Ended

 

March 31

($ millions)

2026

 

2025

Retail sales by product line

 

 

 

Crop nutrients

1,483

 

1,194

Crop protection products

1,137

 

972

Seed

562

 

532

Services and other

175

 

146

Merchandise

223

 

189

Nutrien Financial

80

 

70

Nutrien Financial elimination1

(20)

 

(13)

 

3,640

 

3,090

Potash sales by geography

 

 

 

Manufactured product

 

 

 

North America

484

 

434

Offshore2

557

 

426

Other potash and purchased products

 

1

 

1,041

 

861

Nitrogen sales by product line

 

 

 

Manufactured product

 

 

 

Ammonia

167

 

240

Urea and ESN®

416

 

382

Solutions, nitrates and sulfates

416

 

321

Other nitrogen and purchased products3

132

 

61

 

1,131

 

1,004

Phosphate sales by product line

 

 

 

Manufactured product

 

 

 

Fertilizer

359

 

249

Industrial and feed

183

 

151

Other phosphate and purchased products

5

 

5

 

547

 

405

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2 Relates to Canpotex Limited (“Canpotex”) (see Note 8) and includes provisional pricing adjustments for the three months ended March 31, 2026 of $(3) million (2025 – $31 million).

3 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

Note 3 Other expenses (income)

 

Three Months Ended

 

March 31

($ millions)

2026

 

2025

Restructuring costs

16

 

1

Earnings of equity-accounted investees

(2)

 

(5)

Bad debt expense

15

 

19

Project feasibility costs

18

 

15

Customer prepayment costs

19

 

18

Legal expenses

5

 

5

ARO/ERL related (income) expenses for non-operating sites

(28)

 

5

Impairment of assets

30

 

Other expenses

41

 

10

 

114

 

68

Note 4 Income taxes

 

Three Months Ended

 

March 31

($ millions, except as otherwise noted)

2026

 

2025

Actual effective tax rate on earnings (%)

29

 

49

Actual effective tax rate including discrete items (%)

24

 

60

Discrete tax adjustments that impacted the tax rate1

(8)

 

5

1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

Note 5 Financial instruments

During the three months ended March 31, 2026, we entered into interest rate derivative contracts to manage exposure to changes in variable interest rates on certain long-term debt instruments.

The following table presents the Company’s interest rate derivatives outstanding as at March 31, 2026:

 

As at March 31, 2026

 

 

 

Maturities

 

Average fixed

 

Fair value of

($ millions, except as otherwise noted)

Notional1

 

(year)

 

interest rate (%)

 

assets2

Interest rate derivatives – 5-year

250

 

2026

 

3.6473

 

3

Interest rate derivatives – 10-year

350

 

2026

 

4.0774

 

8

1 Notional amounts represent the gross contractual amount outstanding.

2 Fair value of interest rate derivatives are based on a discounted cash flow model using observable market inputs which are classified as Level 2.

Our financial instruments carrying amounts are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $9,861 million and fair value of $9,372 million as at March 31, 2026. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 6 Debt

On March 3, 2026, we entered into a $69 million uncommitted revolving demand facility. As at March 31, 2026, there were no borrowings outstanding under this facility.

During the three months ended March 31, 2026, we extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028.

Note 7 Share capital

Share repurchase programs

The following table summarizes our share repurchase activities during the periods indicated below:

 

Three Months Ended

 

March 31

($ millions, except as otherwise noted)

2026

 

2025

Number of common shares repurchased for cancellation

2,081,503

 

2,862,814

Average price per share (US dollars)

70.97

 

51.08

Total cost, inclusive of tax

148

 

149

Subsequent to March 31, 2026, as of May 5, 2026, an additional 865,577 common shares were repurchased for cancellation at a cost of $66 million and an average price per share of $73.71.

Dividends declared

We declared a dividend per share of $0.55 (2025 – $0.545) during the three months ended March 31, 2026, payable on April 16, 2026 to shareholders of record on March 31, 2026.

Note 8 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized, at the time product is loaded for shipping, at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended March 31, 2026 were $64 million (2025 – $57 million).

 

 

As at

 

As at

($ millions)

 

March 31, 2026

 

December 31, 2025

Receivables from Canpotex

 

293

 

279

Payables to Canpotex

 

74

 

63

Note 9 Accounting policies, estimates and judgments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The amendments clarified the timing of recognition and derecognition of financial assets and financial liabilities. The adoption resulted in a change in the accounting policy relating to the timing of the derecognition of certain financial assets and financial liabilities, such that derecognition now occurs upon settlement.

The amendments were applied retrospectively without restatement of prior periods in accordance with the transitional provisions other than, on initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the three months ended March 31, 2026.

For Further Information:

Investor Contact:

Jeff Holzman

Senior Vice President, Investor Relations and FP&A

(306) 933-8545 – [email protected]

Media Contact:

Simon Scott

Vice President, Global Communications

(403) 225-7213 – [email protected]

KEYWORDS: United States North America Canada

INDUSTRY KEYWORDS: Agriculture Natural Resources Other Retail Retail Specialty

MEDIA:

Logo
Logo

Precipio Announces Q1-2026 Shareholder Update Call

Conference Call will be held on May 18th, 2026, at 5:00 PM EST

NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2026 shareholder update call on May 18th, 2026, at 5:00 PM ET. The call will include remarks on the company’s current core businesses, as well as a moderated live Q&A session at the end of the Company remarks.

As part of Precipio’s ongoing commitment to transparency and shareholder engagement, this call will be the first time the Company will incorporate a dedicated moderated live Q&A session into its quarterly update call. Management looks forward to addressing investor questions and providing additional insight into the Company’s performance, strategy, and growth initiatives.

Following Ilan Danieli’s remarks, the conference call moderator will invite listeners to log into the Q&A system, where they will need to identify themselves and the organization they represent (or individual investor). Participants who wish to ask a question during the live call should follow the operator’s instructions.

Listeners interested in submitting questions in advance can email their questions to [email protected], and management will do its best to address those questions during the call.

The conference call may be accessed by calling 646.307.1865. All callers should ask for the Precipio Inc. conference call.

A replay of the call will be available approximately 24 hours after the call and may be accessed via the Investors page on Precipio’s website, https://www.precipiodx.com/investors/.

About Precipio

Precipio is a healthcare biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services. Our products and services deliver higher accuracy, improved laboratory workflow, and ultimately better patient outcomes, which reduce healthcare expenses. Precipio develops innovative technologies in our laboratory where we design, test, validate, and use these products clinically, improving diagnostic outcomes. Precipio then commercializes these technologies as proprietary products that serve the global laboratory community and further scales Precipio’s reach to eradicate misdiagnosis.

Availability of Other Information About Precipio

For more information, please visit the Precipio website at https://www.precipiodx.com/ or follow Precipio on X (formerly Twitter) (@PrecipioDx) and LinkedIn (Precipio) and on Facebook. Investors and others should note that we communicate with our investors and the public using our company website (https://www.precipiodx.com), including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on X and LinkedIn. The information that we post on our website or on X or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the targets set herein and related timing. Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, adjusted EBITDA, plans, objectives, expectations, growth or profitability and our potential to reach financial independence are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “will,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and our other reports filed with the U.S. Securities and Exchange Commission. Any such forward-looking statements represent management’s estimates as of the date of this press release only. While we may elect to update such forward-looking statements at some point in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.



Inquiries:
[email protected]
+1-203-787-7888 Ext. 523